2020-04-23	'Kidney impairment is associated with in-hospital death of COVID-19 patients'	'Background: Information on kidney impairment in patients with coronavirus disease 2019 (COVID-19) is limited. This study aims to assess the prevalence and impact of abnormal urine analysis and kidney dysfunction in hospitalized COVID-19 patients in Wuhan. Method: We conducted a consecutive cohort study of COVID-19 patients admitted in a tertiary teaching hospital with 3 branches following a major outbreak in Wuhan in 2020. Hematuria, proteinuria, serum creatinine concentration and other clinical parameters were extracted from the electronic hospitalization databases and laboratory databases. Incidence rate for acute kidney injury (AKI) was examined during the study period. Association between kidney impairment and in-hospital death was analyzed. Results: We included 710 consecutive COVID19 patients, 89 (12.3%) of whom died in hospital. The median age of the patients was 63 years (inter quartile range, 51-71), including 374 men and 336 women. On admission, 44% of patients have proteinuria hematuria and 26.9% have hematuria, and the prevalence of elevated serum creatinine and blood urea nitrogen were 15.5% and 14.1% respectively. During the study period, AKI occurred in 3.2% patients. Kaplan-Meier analysis demonstrated that patients with kidney impairment have higher risk for in-hospital death. Cox proportional hazard regression confirmed that elevated serum creatinine, elevated urea nitrogen, AKI, proteinuria and hematuria was an independent risk factor for in-hospital death after adjusting for age, sex, disease severity, leukocyte count and lymphocyte count. Conclusion: The prevalence of kidney impairment (hematuria, proteinuria and kidney dysfunction) in hospitalized COVID-19 patients was high. After adjustment for confounders, kidney impairment indicators were associated with higher risk of in-hospital death. Clinicians should increase their awareness of kidney impairment in hospitalized COVID-19 patients.'	2020-02-20	10.1101/2020.02.18.20023242	https://www.meta.org/papers/article/1010023242
2020-04-23	'Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography: a prospective study'	'Background: Computed tomography (CT) is the preferred imaging method for diagnosing 2019 novel coronavirus (COVID19) pneumonia. Our research aimed to construct a system based on deep learning for detecting COVID-19 pneumonia on high resolution CT, relieve working pressure of radiologists and contribute to the control of the epidemic. Methods: For model development and validation, 46,096 anonymous images from 106 admitted patients, including 51 patients of laboratory confirmed COVID-19 pneumonia and 55 control patients of other diseases in Renmin Hospital of Wuhan University (Wuhan, Hubei province, China) were retrospectively collected and processed. Twenty-seven consecutive patients undergoing CT scans in Feb, 5, 2020 in Renmin Hospital of Wuhan University were prospectively collected to evaluate and compare the efficiency of radiologists against 2019-CoV pneumonia with that of the model. Findings: The model achieved a per-patient sensitivity of 100%, specificity of 93.55%, accuracy of 95.24%, PPV of 84.62%, and NPV of 100%; a per-image sensitivity of 94.34%, specificity of 99.16%, accuracy of 98.85%, PPV of 88.37%, and NPV of 99.61% in retrospective dataset. For 27 prospective patients, the model achieved a comparable performance to that of expert radiologist. With the assistance of the model, the reading time of radiologists was greatly decreased by 65%. Conclusion: The deep learning model showed a comparable performance with expert radiologist, and greatly improve the efficiency of radiologists in clinical practice. It holds great potential to relieve the pressure of frontline radiologists, improve early diagnosis, isolation and treatment, and thus contribute to the control of the epidemic.'	2020-03-01	10.1101/2020.02.25.20021568	https://www.meta.org/papers/article/1010021568
2020-04-23	'CT Imaging and Differential Diagnosis of COVID-19'	'Since the beginning of 2020, coronavirus disease 2019 (COVID-19) has spread throughout China. This study explains the findings from lung computed tomography images of some patients with COVID-19 treated in this medical institution and discusses the difference between COVID-19 and other lung diseases.'	2020-03-05	10.1177/0846537120913033	https://www.meta.org/papers/article/32129670
2020-04-23	'COVID19 -Nuclear Medicine Departments, be prepared!'	'None'	2020-03-14	10.1097/mnm.0000000000001183	https://www.meta.org/papers/article/32168202
2020-04-23	'Excess cases of Influenza like illnesses in France synchronous with COVID19 invasion.'	'Several French regions where COVID19 has been reported currently show a renewed increase in ILI cases in the general practice based Sentinelles network. Here we computed the number of excess cases by region and found correlation with the number of reported COVID19 cases so far. These data suggest larger circulation of SARS-CoV-2 in the French population than apparent from confirmed cases.'	2020-03-17	10.1101/2020.03.14.20035741	https://www.meta.org/papers/article/1010035741
2020-04-23	'Management strategies for patients with gynecological malignancies during the outbreak of COVID19'	'Objective: To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID19. Methods: We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID19 in Renmin Hospital of Wuhan University in January 2020, and proposed management strategies for patients with gynecological tumors under risk of COVID19. Results: Three patients were treated COVID19 based on the national diagnosis and treatment protocol as well as research progress. Meanwhile, these patients were appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19. Conclusions: Patients with gynecological malignant tumors are high-risk groups prone to COVID-19 infection, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner.'	2020-03-17	10.3760/cma.j.cn112141-20200302-00168	https://www.meta.org/papers/article/32174096
2020-04-23	'A serological assay to detect SARS-CoV-2 seroconversion in humans'	'Introduction: SARS-Cov-2 (severe acute respiratory disease coronavirus 2), which causes Coronavirus Disease 2019 (COVID19) was first detected in China in late 2019 and has since then caused a global pandemic. While molecular assays to directly detect the viral genetic material are available for the diagnosis of acute infection, we currently lack serological assays suitable to specifically detect SARS-CoV-2 antibodies. Methods: Here we describe serological enzyme-linked immunosorbent assays (ELISA) that we developed using recombinant antigens derived from the spike protein of SARS-CoV-2. These assays were developed with negative control samples representing pre-COVID 19 background immunity in the general population and samples from COVID19 patients. Results: The assays are sensitive and specific, allowing for screening and identification of COVID19 seroconverters using human plasma/serum as early as 3 days post symptom onset. Importantly, these assays do not require handling of infectious virus, can be adjusted to detect different antibody types and are amendable to scaling. Conclusion: Serological assays are of critical importance to determine seroprevalence in a given population, define previous exposure and identify highly reactive human donors for the generation of convalescent serum as therapeutic. Sensitive and specific identification of coronavirus SARS-Cov-2 antibody titers will also support screening of health care workers to identify those who are already immune and can be deployed to care for infected patients minimizing the risk of viral spread to colleagues and other patients.'	2020-04-16	10.1101/2020.03.17.20037713	https://www.meta.org/papers/article/1010037713
2020-04-23	'Coronavirus disease-19: The First 7,755 Cases in the Republic of Korea'	'We report the first 7,755 patients with confirmed COVID19 in Korea as of March 13, 2020. A total of 66 deaths were identified, resulting case fatality proportion of 0.9%. Older people, and those with coexisting medical conditions were at risk for fatal outcomes. The highest number of cases were from Daegu, followed by Gyeongbuk, with elevated age-stratified case fatality. This summary may help to understand the disease dynamics in the early phase of COVID19 outbreak, therefore, to guide future public health measures.'	2020-03-18	10.1101/2020.03.15.20036368	https://www.meta.org/papers/article/1010036368
2020-04-23	'Coronavirus disease-19: Summary of 2,370 Contact Investigations of the First 30 Cases in the Republic of Korea'	'Between January 24 and March 10, of a total of 2,370 individuals who had contacted the first 30 cases of COVID19, 13 were found to have COVID19, resulting secondary attack rate of 0.55% (95% CI 0.31 to 0.96). Of 119 household contacts, 9 had infections resulting secondary attack rate of 7.56 (95% CI 3.73 to 14.26).'	2020-03-18	10.1101/2020.03.15.20036350	https://www.meta.org/papers/article/1010036350
2020-04-23	'CoViD--19: An Automatic, Semiparametric Estimation Method for the Population Infected in Italy'	'To date, official data on the number of people infected with the SARS-CoV-2 , responsible for the CoViD19 , have been released by the Italian Government just on the basis of a non representative sample of population which tested positive for the swab. However a reliable estimation of the number of infected, including asymptomatic people, turns out to be crucial in the preparation of operational schemes and to estimate the future number of people, who will require, to different extents, medical attentions. In order to overcome the current data shortcoming, this paper proposes a bootstrap driven, estimation procedure for the number of people infected with the SARSCoV2. This method is designed to be robust, automatic and suitable to generate estimations at regional level. Obtained results show that, while official data at March the 12th report 12.839 cases in Italy, people infected wiyh the SARSCoV2 could be as high as 105.789.'	2020-03-18	10.1101/2020.03.14.20036103	https://www.meta.org/papers/article/1010036103
2020-04-23	'Genomic epidemiology of a densely sampled COVID19 outbreak in China'	"Analysis of genetic sequence data from the pandemic SARS Coronavirus 2 can provide insights into epidemic origins, worldwide dispersal, and epidemiological history. With few exceptions, genomic epidemiological analysis has focused on geographically distributed data sets with few isolates in any given location. Here we report an analysis of 20 whole SARS-CoV 2 genomes from a single relatively small and geographically constrained outbreak in Weifang, People's Republic of China. Using Bayesian model-based phylodynamic methods, we estimate the reproduction number for the outbreak to be 1.99(95% CI:1.48-3.14). We further estimate the number of infections through time and compare these estimates to confirmed diagnoses by the Weifang Centers for Disease Control. We find that these estimates are consistent with reported cases and there is unlikely to be a large undiagnosed burden of infection over the period we studied."	2020-03-19	10.1101/2020.03.09.20033365	https://www.meta.org/papers/article/1010033365
2020-04-23	'Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan, China'	"Background: Coronavirus Disease 2019 (COVID19) is currently a global public health threat. Outside of China, Italy is one of the most suffering countries with the COVID19 epidemic. It is important to predict the epidemics trend of COVID19 epidemic in Italy to help develop public health strategies. Methods: We used time series data of COVID 19 from Jan 22,2020 to Mar 16,2020. An infectious disease dynamic extended susceptible infected removed (eSIR) model, which covers the effects of different intervention measures in dissimilar periods, was applied to estimate the epidemic trend in Italy. The basic reproductive number was estimated using Markov Chain Monte Carlo methods and presented using the resulting posterior mean and 95% credible interval (CI). Hunan, with similar total number of populations in Italy, was used as a comparative item. Results: In the eSIR model, we estimated that the basic reproductive number for COVID 19 was respectively 4.10 (95% CI: 2.15 to 6.77) in Italy and 3.15(95% CI: 1.71 to 5.21) in Hunan. There would be totally 30 086 infected cases (95%CI:7920-81 869) under the current country blockade and the endpoint would be Apr 25 (95%CI: Mar 30 to Aug 07) in Italy. If the country blockade is imposed 5 day later, the total number of infected cases would expand the infection scale 1.50 times. Conclusion: Italy's current strict measures can efficaciously prevent the further spread of COVID19 and should be maintained. Necessary strict public health measures be implemented as soon as possible in other European countries with a high number of COVID19 cases. The most effective strategy needs to be confirmed in further studies."	2020-03-20	10.1101/2020.03.18.20038570	https://www.meta.org/papers/article/1010038570
2020-04-23	'A Novel Triage Tool of Artificial Intelligence Assisted Diagnosis Aid System for Suspected COVID-19 pneumonia In Fever Clinics'	'Currently, the prevention and control of COVID-19 outside Hubei province in China, and other countries has become more and more critically serious. We developed and validated a diagnosis aid model without CT images for early identification of suspected COVID-19 pneumonia (S-COVID-19-P) on admission in adult fever patients and made the validated model available via an online triage calculator. Patients admitted from Jan 14 to Feb 26, 2020 with the epidemiological history of exposure to COVID-19 were included [Model development (n = 132) and validation (n = 32)]. Candidate features included clinical symptoms, routine laboratory tests and other clinical information on admission. Features selection and model development were based on Lasso regression. The primary outcome is the development and validation of a diagnosis aid model for S-COVID-19-P early identification on admission. The development cohort contains 26 S-COVID-19-P and 7 confirmed COVID-19 pneumonia cases. The model performance in held-out testing set and validation cohort resulted in AUCs of 0.841 and 0.938, F-1 score of 0.571 and 0.667, recall of 1.000 and 1.000, specificity of 0.727 and 0.778, and the precision of 0.400 and 0.500. Based on this model, an optimized strategy for S-COVID-19-P early identification in fever clinics has also been designed. S-COVID-19-P could be identified early by a machine-learning model only used collected clinical information without CT images on admission in fever clinics with 100% recall score. The well performed and validated model has been deployed as an online triage tool, which is available at: https://intensivecare.shinyapps.io/COVID19/.'	2020-03-20	10.1101/2020.03.19.20039099	https://www.meta.org/papers/article/1010039099
2020-04-23	'A Trip through Southeast Asian Airports in Times of COVID19'	'A Trip through Southeast Asian Airports in Times of COVID19.'	2020-03-20	10.4269/ajtmh.20-0153	https://www.meta.org/papers/article/32189617
2020-04-23	'Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March\xa02020'	"The current outbreak of coronavirus disease (COVID-19) has reached Germany. The majority of people infected present with mild disease, but there are severe cases that need intensive care. Unlike other acute infectious diseases progressing to sepsis, the severe courses of COVID19 seemingly show prolonged progression from onset of first symptoms to life-threatening deterioration of (primarily) lung function. Diagnosis relies on PCR using specimens from the respiratory tract. Severe ARDS reflects the hallmark of a critical course of the disease. Preventing nosocomial infections (primarily by correct use of personal protective equipment) and maintenance of hospitals' operational capability are of utmost importance. Departments of Anaesthesia, Intensive Care and emergency medicine will envisage major challenges."	2020-03-20	10.1007/s00101-020-00758-x	https://www.meta.org/papers/article/32189015
2020-04-23	'A mathematical model for the spatiotemporal epidemic spreading of COVID19'	'An outbreak of a novel coronavirus, named SARS-CoV-2, that provokes the COVID-19 disease, was first reported in Hubei, mainland China on 31 December 2019. As of 20 March 2020, cases have been reported in 166 countries/regions, including cases of human-to-human transmission around the world. The proportions of this epidemics is probably one of the largest challenges faced by our interconnected modern societies. According to the current epidemiological reports, the large basic reproduction number, R_0 ~ 2.3, number of secondary cases produced by an infected individual in a population of susceptible individuals, as well as an asymptomatic period (up to 14 days) in which infectious individuals are undetectable without further analysis, pave the way for a major crisis of the national health capacity systems. Recent scientific reports have pointed out that the detected cases of COVID19 at young ages is strikingly short and that lethality is concentrated at large ages. Here we adapt a Microscopic Markov Chain Approach (MMCA) metapopulation mobility model to capture the spread of COVID-19. We propose a model that stratifies the population by ages, and account for the different incidences of the disease at each strata. The model is used to predict the incidence of the epidemics in a spatial population through time, permitting investigation of control measures. The model is applied to the current epidemic in Spain, using the estimates of the epidemiological parameters and the mobility and demographic census data of the national institute of statistics (INE). The results indicate that the peak of incidence will happen in the first half of April 2020 in absence of mobility restrictions. These results can be refined with improved estimates of epidemiological parameters, and can be adapted to precise mobility restrictions at the level of municipalities. The current estimates largely compromises the Spanish health capacity system, in particular that for intensive care units, from the end of March. However, the model allows for the scrutiny of containment measures that can be used for health authorities to forecast with accuracy their impact in prevalence of COVID--19. Here we show by testing different epidemic containment scenarios that we urge to enforce total lockdown to avoid a massive collapse of the Spanish national health system.'	2020-03-23	10.1101/2020.03.21.20040022	https://www.meta.org/papers/article/1010040022
2020-04-23	'The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis'	'Background The novel coronavirus COVID19 has been classified by the World Health Organisation as a pandemic due to its worldwide spread. The ability of countries to contain and control transmission is critical in the absence of a vaccine. We evaluated a range of social distancing measures to determine which strategies are most effective in reducing the peak daily infection rate, and consequential pressure on the health care system. Methods Using COVID19 transmission data from the outbreak source in Hubei Province, China, collected prior to activation of containment measures, we adapted an established individual based simulation model of the city of Newcastle, Australia, population 272,409. Simulation of virus transmission in this community model without interventions provided a baseline from which to compare alternative social distancing strategies. The infection history of each individual was determined, as was the time infected. From this model generated data, the rate of growth in cases, the magnitude of the epidemic peak, and the outbreak duration were obtained. Findings The application of all four social distancing interventions: school closure, workplace non-attendance, increased case isolation, and community contact reduction is highly effective in flattening the epidemic curve, reducing the maximum daily case numbers, and lengthening outbreak duration. These were also found to be effective even after 10 weeks delay from index case arrivals. The most effective single intervention was found to be increasing case isolation, to 100 percent of children and 90 percent of adults. Interpretation As strong social distancing intervention strategies had the most effect in reducing the epidemic peak, this strategy may be considered when weaker strategies are first tried and found to be less effective. Questions arise as to the duration of strong social distancing measures, given they are highly disruptive to society. Tradeoffs may need to be made between the effectiveness of social distancing strategies and population willingness to adhere to them.'	2020-03-23	10.1101/2020.03.20.20040055	https://www.meta.org/papers/article/1010040055
2020-04-23	'ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19'	'Introduction: Coronavirus disease 2019 (COVID-19) is a respiratory infection caused by the severe acute respiratory syndrome coronavirus2 (SARSCoV-2). This virus uses the angiotensin converting enzyme II (ACE2) as the cellular entry receptor to infect the lower respiratory tract. Because individuals with chronic obstructive pulmonary disease (COPD) are at increased risk of severe COVID19, we determined whether ACE2 expression in the lower airways was related to COPD and cigarette smoking. Methods: Using RNAseq, we determined gene expression levels in bronchial epithelia obtained from cytologic brushings of 6th to 8th generation airways in individuals with and without COPD. We externally validated these results from two additional independent cohorts, which used microarray technologies to measure gene expression levels from 6th to 12th generation airways. Results: In the discovery cohort (n=42 participants), we found that ACE2 expression levels were increased by 48% in the airways of COPD compared with non-COPD subjects (COPD=2.52 (0.66) log2 counts per million reads (CPM) versus non-COPD= 1.70 (0.51) CPM , p=.000762). There was a significant inverse relationship between ACE2 gene expression and FEV1% of predicted (r=negative 0.24; p=0.035). Current smoking also significantly increased ACE2 expression levels compared with never smokers (never current smokers=2.77 (90.91) CPM versus smokers=1.78 (0.39) CPM, p=0.024). These findings were replicated in the two external cohorts. Conclusions: ACE2 expression in lower airways is increased in patients with COPD and with current smoking. These data suggest that these two subgroups are at increased risk of serious COVID19 infection and highlight the importance of smoking cessation in reducing the risk.'	2020-03-23	10.1101/2020.03.18.20038455	https://www.meta.org/papers/article/1010038455
2020-04-23	'Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy'	'None'	2020-03-24	10.1016/j.jhin.2020.03.018	https://www.meta.org/papers/article/32201338
2020-04-23	'A COVID-19 Transmission within a family cluster by presymptomatic infectors in China'	'We report a COVID-19 family cluster caused by a presymptomatic case. There were 9 family members, including 8 laboratory-confirmed with COVID-19, and a 6-year-old child had no evidence of infection. Amongst the 8 patients, one adult and one 13-month-old infant were asymptomatic, one adult was diagnosed as having severe pneumonia.'	2020-03-24	10.1093/cid/ciaa316	https://www.meta.org/papers/article/32201889
2020-04-23	'COVID-19 Epidemic in the Middle Province of Northern Italy: Impact, Logistics, and Strategy in the First Line Hospital'	'The novel coronavirus (COVID-19) began in China in early December 2019 and rapidly has spread to many countries around the globe, with the number of confirmed cases increasing every day. An epidemic has been recorded since February 20 in a middle province in Northern Italy (Lodi province, in the low Po Valley). The first line hospital had to redesign its logistical and departmental structure to respond to the influx of COVID-19-positive patients who needed hospitalization. Logistical and structural strategies were guided by the crisis unit, managing in 8 days from the beginning of the epidemic to prepare the hospital to be ready to welcome more than 200 COVID-19-positive patients with different ventilatory requirements, keeping clean emergency access lines, and restoring surgical interventions and deferred urgent, routine activity.'	2020-03-25	10.1017/dmp.2020.51	https://www.meta.org/papers/article/32207676
2020-04-23	'COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis'	'Objectives: The rapidly evolving coronavirus disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on March 11, 2020. It was first detected in the city of Wuhan in China and has spread globally resulting in substantial health and economic crisis in many countries. Observational studies have partially identified the different aspects of this disease. Up to this date, no comprehensive systematic review for the clinical, laboratory, epidemiologic and mortality findings has been published. We conducted this systematic review and meta-analysis for a better understanding of COVID-19. Methods: We reviewed the scientific literature published from January 1, 2019 to March 3, 2020. Statistical analyses were performed with STATA (version 14, IC; Stata Corporation, College Station, TX, USA). The pooled frequency with 95% confidence intervals (CI) was assessed using random effect model. Publication bias was assessed and p <0.05 was considered a statistically significant publication bias. Results: Out of 1102 studies, 32 satisfied the inclusion criteria. A total of 4789 patients with a mean age of 49 years were evaluated. Fever (83.0%, CI 77.5 to 87.6), cough (65.2%, CI 58.6 to 71.2) and myalgia/fatigue (34.7, CI 26.0 to 44.4) were the most common symptoms. The most prevalent comorbidities were hypertension (18.5 %, CI 12.7 to 24.4) and Cardiovascular disease (14.9 %, CI 6.0 to 23.8). Among the laboratory abnormalities, elevated C-Reactive Protein (CRP) (72.0% (CI 54.3 to 84.6) and lymphopenia (50.1%, CI 38.0 to 62.4) were the most common findings. Bilateral ground-glass opacities (66.0%, CI 51.1 to 78.0) was the most common CT-Scan presentation. Pooled mortality rate was 6.6%, with males having significantly higher mortality compared to females (OR 3.4; 95% CI 1.2 to 9.1, P = 0.01). Conclusion: COVID-19 commonly presented with a progressive course of cough and fever with more than half of hospitalized patients showing leukopenia or a high CRP on their laboratory findings. Mortality associated with COVID19 was higher than that reported in studies in China with Males having a 3-fold higher risk of mortality in COVID19 compared to females.'	2020-03-26	10.1101/2020.03.24.20042903	https://www.meta.org/papers/article/1010042903
2020-04-23	'Is a COVID19 Quarantine Justified in Chile or USA Right Now?'	'During the current COVID-19 pandemic it is imperative to give early warnings to reduce mortality. However, non-specialist such as authorities and the general population face several problems to understand the real thread of this pandemic, and under/overestimation of its risk are a commonplace in the press and social media. Here we define an index, which we call the COVID-19 Burden Index, that relates the capacities of the healthcare system of a given country to treat severe and critical cases. Its value is 0 if there is no extra strain in the healthcare system, and it reaches 1.0 when the collapse is imminent. As of 23 March 2020, we show that Chile, the USA, UK, among other countries, must reduce the rate of infections right now, otherwise, in less than 7 days they could be in a catastrophic situation such as Italy, Spain and Iran.'	2020-03-27	10.1101/2020.03.23.20042002	https://www.meta.org/papers/article/1010042002
2020-04-23	'Is Hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19?'	'None'	2020-03-27	10.1093/cid/ciaa320	https://www.meta.org/papers/article/32211764
2020-04-23	'Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020'	"The current outbreak of coronavirus disease (COVID-19) has reached Germany. The majority of people infected present with mild disease, but there are severe cases that need intensive care. Unlike other acute infectious diseases progressing to sepsis, the severe courses of COVID19 seemingly show prolonged progression from onset of first symptoms to life-threatening deterioration of (primarily) lung function. Diagnosis relies on PCR using specimens from the respiratory tract. Severe ARDS reflects the hallmark of a critical course of the disease. Preventing nosocomial infections (primarily by correct use of personal protective equipment) and maintenance of hospitals' operational capability are of utmost importance. Departments of Anaesthesia, Intensive Care and emergency medicine will envisage major challenges."	2020-03-27	10.1007/s00101-020-00760-3	https://www.meta.org/papers/article/32211920
2020-04-23	'Estimating Preventable COVID19 Infections Related to Elective Outpatient Surgery in Washington State: A Quantitative Model'	'Background: As the number of suspected and confirmed COVID19 cases in the US continues to rise, the US surgeon general, Centers for Disease Control and Prevention, and several specialty societies have issued recommendations to consider canceling elective surgeries. However, these recommendations have also faced controversy and opposition. Methods: Using previously published information and publicly available data on COVID19 infections, we calculated a transmission rate and generated a mathematical model to predict a lower bound for the number of healthcare-acquired COVID19 infections that could be prevented by canceling or postponing elective outpatient surgeries in Washington state. Results: Our model predicts that over the course of 30 days, at least 75.9 preventable patient infections and at least 69.3 preventable healthcare worker (HCW) infections would occur in WA state alone if elective outpatient procedures were to continue as usual. Conclusion: Canceling elective outpatient surgeries during the COVID19 pandemic could prevent a large number of patient and healthcare worker infections.'	2020-03-27	10.1101/2020.03.18.20037952	https://www.meta.org/papers/article/1010037952
2020-04-23	'Climate effect on COVID-19 spread rate: an online surveillance tool'	'Background: COVID-19 outbreak poses an unprecedented challenge for societies, healthcare organizations and economies. In the present analysis we coupled climate data with COVID-19 spread rates worldwide, and in a single country (USA). Methods: Data of confirmed COVID-19 cases was derived from the COVID-19 Global Cases by the CSSE at Johns Hopkins University up to March 19, 2020. We assessed disease spread by two measures: replication rate (RR), the slope of the logarithmic curve of confirmed cases, and the rate of spread (RoS), the slope of the linear regression of the logarithmic curve. Results: Based on predefined criteria, the mean COVID-19 RR was significantly lower in warm climate countries (0.12{+/-} 0.02) compared with cold countries (0.24{+/-} 0.01), (P<0.0001). Similarly, RoS was significantly lower in warm climate countries 0.12{+/-} 0.02 vs. 0.25{+/-} 0.01 than in cold climate countries (P<0.001). In all countries (independent of climate classification) both RR and RoS displayed a moderate negative correlation with temperature R= -0.69, 95% confidence interval [CI], -0.87 to -0.36; P<0.001 and R= -0.72, 95% confidence interval [CI], -0.87 to -0.36; P<0.001, respectively. We identified a similar moderate negative correlation with the dew point temperature. Additional climate variables did not display a significant correlation with neither RR nor RoS. Finally, in an ancillary analysis, COVID-19 intra-country model using an inter-state analysis of the USA did not identify yet correlation between climate parameters and RR or RoS as of March, 19, 2020. Conclusions: Our analysis suggests a plausible negative correlation between warmer climate and COVID-19 spread rate as defined by RR and RoS worldwide. This initial correlation should be interpreted cautiously and be further validated over time, the pandemic is at different stages in various countries as well as in regions within these countries. As such, some associations may be more affected by local transmission patterns rather than by climate. Importantly, we provide an online surveillance dashboard (https://covid19.net.technion.ac.il/) to further assess the association between climate parameters and outbreak dynamics worldwide as time goes by'	2020-03-30	10.1101/2020.03.26.20044727	https://www.meta.org/papers/article/1010044727
2020-04-23	'Indications for healthcare surge capacity in European countries facing an exponential increase in COVID19 cases'	'European healthcare systems face extreme pressure from COVID-19. We estimate such pressure by relating both country-specific accumulated COVID-19 deaths (intensity-approach) and active COVID-19 cases (magnitude-approach) to measures of healthcare system capacity: hospital beds, healthcare workers and healthcare expenditure. On March 25, 2020 - relative to Italy on March 11- we found Spain, The Netherlands and France to experience the highest pressure using the intensity-approach with a composite measure for healthcare capacity. For updates see www.covid-hcpressure.org'	2020-03-30	10.1101/2020.03.14.20035980	https://www.meta.org/papers/article/1010035980
2020-04-23	'Suppression and Mitigation Strategies for Control of COVID-19 in New Zealand'	'A standard SEIR-type compartment model, parameterised for New Zealand, was used to simulate the spread of Covid19 in New Zealand and to test the effectiveness of various control strategies. Control aims can be broadly categorised as either suppression or mitigation. Suppression aims to keep cases to an absolute minimum for as long as possible. Mitigation aims to allow a controlled outbreak to occur, with the aim of preventing significant overloads on healthcare systems and gradually allowing the population to develop herd immunity. Both types of strategy are fraught with uncertainty. Suppression strategies can succeed in delaying an outbreak, but only for as long as such control measures can be sustained. Once controls are eased or restricted, an epidemic is likely to follow as no herd immunity has been acquired. The success or failure of mitigation strategies can depend sensitively on the timing and efficacy of control measures, and require the ability to bring rapidly growing outbreaks under immediate control when needed. This is as yet untested even for a combination of national interventions including case isolation, household quarantine, population-wide social distancing and closure of schools and universities. Although there are disadvantages to both types of approach, suppression has the advantage of buying time until a vaccine and/or treatment become available and allowing NZ to learn from rapidly unfolding events in other countries. A combination of successful suppression, strong border measures, and widespread contact tracing and testing resulting in containment could allow periods when control measures can be relaxed, but only if cases are reduced to a handful.'	2020-03-30	10.1101/2020.03.26.20044677	https://www.meta.org/papers/article/1010044677
2020-04-23	'Effects of temperature on COVID-19 transmission'	'Coronavirus disease 2019 (COVID19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV2), it was first identified in 2019 in Wuhan, China and has resulted in the 2019-20 coronavirus pandemic. As of March 1, 2020, 79,968 patients in China and 7169 outside of China had tested positive for COVID19 and a mortality rate of 3.6% has been observed amongst Chinese patients. Its primary mode of transmission is via respiratory droplets from coughs and sneezes. The virus can remain viable for up to three days on plastic and stainless steel or in aerosols for upto 3 hours and is relatively more stable than the known human coronaviruses. It is stable in faeces at room temperature for at least 1-2 days and can be stable in infected patients for up to 4 days. Heat at 56 degree Celsius kills the SARS coronavirus at around 10000 units per 15 minutes. Thus, temperature is an important factor in survival of COVID19 virus and this article focuses on understanding the relationship between temperature and COVID19 transmission from the data available between January-March 2020.'	2020-03-30	10.1101/2020.03.29.20044461	https://www.meta.org/papers/article/1010044461
2020-04-23	'Projecting the Spread of COVID19 for Germany'	'We model the evolution of the number of individuals that are reported to be sick with COVID-19 in Germany. Our theoretical framework builds on a continuous time Markov chain with four states: healthy without infection, sick, healthy after recovery or after infection but without symptoms and dead. Our quantitative solution matches the number of sick individuals up to the most recent observation and ends with a share of sick individuals following from infection rates and sickness probabilities. We employ this framework to study inter alia the expected peak of the number of sick individuals in a scenario without public regulation of social contacts. We also study the effects of public regulations. For all scenarios we report the expected end of the CoV-2 epidemic. We have four general findings: First, current epidemiological thinking implies that the long-run effects of the epidemic only depend on the aggregate long-run infection rate and on the individual risk to turn sick after an infection. Any measures by individuals and the public therefore only influence the dynamics of spread of CoV-2. Second, predictions about the duration and level of the epidemic must strongly distinguish between the officially reported numbers (Robert Koch Institut, RKI) and actual numbers of sick individuals. Third, given the current (scarce) medical knowledge about long-run infection rate and individual risks to turn sick, any prediction on the length (duration in months) and strength (e.g. maximum numbers of sick individuals on a given day) is subject to a lot of uncertainty. Our predictions therefore offer robustness analyses that provide ranges on how long the epidemic will last and how strong it will be. Fourth, public interventions that are already in place and that are being discussed can lead to more and less severe outcomes of the epidemic. If an intervention takes place too early, the epidemic can actually be stronger than with an intervention that starts later. Interventions should therefore be contingent on current infection rates in regions or countries. Concerning predictions about COVID-19 in Germany, we find that the long-run number of sick individuals (that are reported to the RKI), once the epidemic is over, will lie between 500 thousand and 5 million individuals. While this seems to be an absurdly large range for a precise projection, this reflects the uncertainty about the long-run infection rate in Germany. If we assume that Germany will follow the good scenario of Hubei (and we are even a bit more conservative given discussions about data quality), we will end up with 500 thousand sick individuals over the entire epidemic. If by contrast we believe (as many argue) that once the epidemic is over 70% of the population will have been infected (and thereby immune), we will end up at 5 million cases. Defining the end of the epidemic by less than 100 newly reported sick individuals per day, we find a large variation depending on the effectiveness of governmental pleas and regulations to reduce social contacts. An epidemic that is not influenced by public health measures would end mid June 2020. With public health measures lasting for few weeks, the end is delayed by around one month or two. The advantage of the delay, however, is to reduce the peak number of individuals that are simultaneously sick. When we believe in long-run infection rates of 70%, this number is equally high for all scenarios we went through and well above 1 million. When we can hope for the Hubei-scenario, the maximum number of sick individuals will be around 200 thousand only. Whatever value of the range of long-run infection rates we want to assume, the epidemic will last at least until June, with extensive and potentially future public health measures, it will last until July. In the worst case, it will last until end of August. We emphasize that all projections are subject to uncertainty and permanent monitoring of observed incidences are taken into account to update the projection. The most recent projections are available at https://www.macro.economics.uni-mainz.de/corona-blog/.'	2020-03-30	10.1101/2020.03.26.20044214	https://www.meta.org/papers/article/1010044214
2020-04-23	'Modeling the Corona Virus Outbreak in IRAN'	'Background: As the outbreak of coronavirus disease 2019 (COVID19) is a worldwide pandemic it is rapidly expanding in Iran realtime analyses of epidemiological data are needed to increase situational awareness and inform interventions. In this study we built a predictive model based on the cumulative trend of new cases and deaths for the top five provinces. we will also look at modeling the trends for confirmed cases deaths and recovered for the whole country. Method: In this study we have chosen to apply the exponential smoothing model to iteratively forecast future values of a regular time seires from weighted averages of past daily values of the series. This method is exponential because the value of each level is influenced by every preceeding actual value to an exponentially decreasing degree more recent values are given a greater weight. The available data is too small to identify seasonal patterns and make predictable variation in value, such as annual fluctuation in temperature relative to the season. Trend is a tendency in the data to increase or decrease over time. Results: If no control measures are put in place it is expected that over 40000 would be infected in Tehran around the middle of June. However if control measures were implemented with a high degree of success one would expect the spread of the COV19 virus would peak at the start of April with a downward trend dropping off by the end of May (70 days). In the scenario that no further measures are implemented, one would expect the spread of COVID19 to continue on a gentle incline reaching 21000 by mid-June. The same process has been applied to review the confirmed deaths and recovered dataset. The forecast has been carried out for the next 30 days a shorter timeframe has been selected as there is a high probability that the Iranian New Years celebration Farvardin first month of Spring (30th March in Western calendar) will have an impact on the infection rate following the event. The best predictive model predicts the confirmed cases to be in the range of 35000 70000 with the number of reported COVDI-19 deaths to be between 3000 5000 and 5000 30000 of recovered cases. Conclusions: Modeling outbreak ofCovid19 shows that the number of patients and deaths is still increasing. Contagious diseases follow an exponential model and the same be Haves this one. This is because the virus can spread to others and finally each person turns into a carrier of the virus and transmit it to another person. Disease control depends on disconnection and social distancing. In addition many factors are effective in stopping the disease. These include citizens participation in the prevention process health education the effectiveness of instructive traditions environmental conditions and so on.'	2020-03-31	10.1101/2020.03.24.20041095	https://www.meta.org/papers/article/1010041095
2020-04-23	'Analysis of the Worldwide Corona Virus (COVID-19) Pandemic Trend;A Modelling Study to Predict Its Spread'	'Objective: The Coronavirus (COVID-19) has advanced into 197 countries and territories leaving behind a total of 372,757 confirmed cases and 16231 deaths. Methods: One the basis of WHO situation reports data of COVID-19 along with daily official reports from the Japan, China and the Korea we modeled the spread of COVID19 by using the Successive Approximation Method. We defined the two state of data to find the mean ratio ({eta}) of the present cases count to the sum of previous and present cases. This ratio further predicts the future state of COVID-19 pandemic. Results: The mean ratio ({eta}) of expected cases were found 0.485, while the mean ratio for deaths was found to be 0.49. We calculated worldwide expected lower bound value for confirmed cases 247007 cases with maximum limit of 1667719 cases and minimum deaths count 8660 with upper limit of 117397 deaths in next 30 days. While in the case of Iran, a large increase in the number of deaths are expected in the upcoming 30 days with lower bound value of 1140 deaths and maximum value of 598478 deaths. Interpretation: Iran whole population is on risk.'	2020-04-01	10.1101/2020.03.30.20048215	https://www.meta.org/papers/article/1010048215
2020-04-23	'Patterns of the COVID19 epidemic spread around the world: exponential vs power laws'	'We have analyzed the COVID19 epidemic data of more than 174 countries (excluding China) in the period between January 22 and March 28, 2020. We found that some countries (such as the US, the UK, and Canada) follow an exponential epidemic growth, while others (like Italy and several other European countries) show a power law like growth. At the same time, regardless of the best fitting law, most countries can be shown to follow a trajectory similar to that of Italy, but with varying degrees of delay. We found that countries with ``younger" epidemics tend to exhibit more exponential like behavior, while countries that are closer behind Italy tend to follow a power law growth. We hypothesize that there is a universal growth pattern of this infection that starts off as exponential and subsequently becomes more power law like. Although it cannot be excluded that this growth pattern is a consequence of social distancing measures, an alternative explanation is that it is an intrinsic epidemic growth law, dictated by a spatially distributed community structure, where the growth in individual highly mixed communities is exponential but the longer term, local geographical spread (in the absence of global mixing) results in a power-law. This is supported by computer simulations of a metapopulation model that gives rise to predictions about the growth dynamics that are consistent with correlations found in the epidemiological data. Therefore, seeing a deviation from straight exponential growth may not be a consequence of working non-pharmaceutical interventions (except for, perhaps, restricting the air travel). Instead, this is a normal course of raging infection spread. On the practical side, this cautions us against overly optimistic interpretations of the countries epidemic development and emphasizes the need to continue improving the compliance with social distancing behavior recommendations.'	2020-04-01	10.1101/2020.03.30.20047274	https://www.meta.org/papers/article/1010047274
2020-04-23	'How could artificial intelligence aid in the fight against coronavirus?'	'None'	2020-04-01	10.1080/14787210.2020.1744275	https://www.meta.org/papers/article/32223349
2020-04-23	'Fast nosocomial spread of SARS-CoV2 in a French geriatric unit Lyon Study Group on Covid-19 infection'	'Lyon Study Group on Covid19 infection (Geriatric section- Alphabetic order): Adrait, A, Benoist F, Castel-Kremer E, Chuzeville M, Dupin AC, Doh S, Kim B, Favrelle L, Hilliquin D, Kanafer N, Marion E, Martin-Gaujard G, Moyenin Y, Paulet-Lafuma H, Ricanet A, Saadatian-Elahi M, Vanhems P.'	2020-04-01	10.1017/ice.2020.99	https://www.meta.org/papers/article/32223768
2020-04-23	'Forecasting the CoViD19 Diffusion in Italy and the Related Occupancy of Intensive Care Units'	'This paper provides a model based method for the forecast of the total number of currently CoVoD19 positive individuals and of the occupancy of the available Intensive Care Units in Italy. The predictions obtained, for a time horizon of 10 days starting from March 29th, will be provided at a national as well as at a more disaggregate levels, following a criterion based on the magnitude of the phenomenon. While the Regions which have been hit the most by the pandemic have been kept separated, the less affected ones have been aggregated into homogeneous macroareas. Results show that , within the forecast period considered (March 29th April 7th ) , all of the Italian regions will show a decreasing number of CoViD-19 positive people. Same for the number of people who will need to be hospitalized in a Intensive Care Unit (ICU). These estimates are valid under constancy of the Government s current containment policies. In this scenario, Northern Regions will remain the most affected ones and no significant outbreak are foreseen in the southern regions.'	2020-04-01	10.1101/2020.03.30.20047894	https://www.meta.org/papers/article/1010047894
2020-04-23	'Creating a Palliative Care Inpatient Response Plan for COVID19 - The UW Medicine Experience'	'The COVID-19 pandemic is stressing healthcare systems throughout the world. Significant numbers of patients are being admitted to the hospital with severe illness, often in the setting of advanced age and underlying co-morbidities. Therefore, palliative care is an important part of the response to this pandemic. The Seattle area and UW Medicine have been on the forefront of the pandemic in the US. UW Medicine developed a strategy to implement a palliative care response for a multi-hospital healthcare system that incorporates conventional capacity, contingency capacity, and crisis capacity. The strategy was developed by our palliative care programs with input from the healthcare system leadership. In this publication, we share our multi-faceted strategy to implement high-quality palliative care in the context of the COVID-19 pandemic that incorporates conventional, contingency, and crisis capacity and focuses on the areas of the hospital caring for the most patients: the emergency department, the intensive care units, and the acute care services. The strategy focuses on key content areas including identifying and addressing goals of care, addressing moderate and severe symptoms, and supporting family members. Strategy planning for delivery of high-quality palliative care in the context of the COVID-19 pandemic represents an important area of need for our healthcare systems. We share our experiences developing such a strategy to help other institutions conduct and adapt such strategies more quickly.'	2020-04-03	10.1016/j.jpainsymman.2020.03.025	https://www.meta.org/papers/article/32240754
2020-04-23	'Does COVID19 infect the brain? If so, smokers might be at a higher risk '	'COVID19 is a devastating global pandemic with epicenters in China, Italy, Spain, and now the United States. While the majority of infected cases appear mild, in some cases individuals present serious cardiorespiratory complications with possible long-term lung damage. Infected individuals report a range of symptoms from headaches to shortness of breath to taste and smell loss. To that end, less is known about the how the virus may impact different organ systems. The SARS-CoV2 virus, which is responsible for COVID19, is highly similar to SARS-CoV. Both viruses have evolved an ability to enter host cells through direct interaction with the angiotensin converting enzyme 2 (ACE2) protein at the surface of many cells. Published findings indicate that SARS-CoV can enter the human nervous system with evidence from both postmortem brains and detection in cerebrospinal fluid of infected individuals. Here we consider the ability of SARS-CoV2 to enter and infect the human nervous system based on the strong expression of the ACE2 target throughout the brain. Moreover, we predict that nicotine exposure through various kinds of smoking (cigarettes, e-cigarettes, or vape) can increase the risk for COVID19 neuroinfection based on known functional interactions between the nicotinic receptor and ACE2. We advocate for higher surveillance and analysis of neuro-complications in infected cases.'	2020-04-03	10.1124/molpharm.120.000014	https://www.meta.org/papers/article/32238438
2020-04-23	'COVID-19 in patients with cardiovascular diseases'	'None'	2020-04-05	10.1016/j.acvd.2020.03.009	https://www.meta.org/papers/article/32245656
2020-04-23	'Amantadine disrupts lysosomal gene expression; potential therapy for COVID19'	'SARS-coronavirus 2 is the causal agent of the COVID-19 outbreak. SARS-Cov-2 entry into a cell is dependent upon binding of the viral spike (S) protein to cellular receptor and on cleavage of the spike protein by the host cell proteases such as Cathepsin L and Cathepsin B. CTSL/B are crucial elements of lysosomal pathway and both enzymes are almost exclusively located in the lysosomes.CTSL disruption offers potential for CoVID-19 therapies. The mechanisms of disruption include: decreasing expression of CTSL, direct inhibition of CTSL activity and affecting the conditions of CTSL environment (increase pH in lysosomes). We have conducted a high throughput drug screen gene expression analysis to identify compounds that would downregulate the expression of CTSL/CTSB. One of the top significant results shown to downregulate the expression of the CTSL gene is Amantadine. Amantadine was approved by the US Food and Drug Administration in 1968 as a prophylactic agent for influenza and later for Parkinsons disease. It is available as a generic drug. Amantadine in addition to downregulating CTSL appears to further disrupt lysosomal pathway , hence interfering with the capacity of the virus to replicate. It acts as a lysosomotropic agent altering the CTSL functional environment. We hypothesize that Amantadine could decrease the viral load in SARS-CoV-2 positive patients and as such it may serve as a potent therapeutic decreasing the replication and infectivity of the virus likely leading to better clinical outcomes. Clinical studies will be needed to examine the therapeutic utility of amantadine in COVID-19 infection.'	2020-04-05	10.1101/2020.04.05.026187	https://www.meta.org/papers/article/990026187
2020-04-23	'New measures for COVID-19 response: a lesson from the Wenzhou experience'	'As the outbreak of COVID-19 has spread globally, determining how to prevent the spread is of paramount importance. We reported the effectiveness of different responses of four affected cities in preventing the COVID-19 spread. We expect Wenzhou anti-COVID-19 measures may provide experience for cities around the world that are experiencing this epidemic.'	2020-04-05	10.1093/cid/ciaa386	https://www.meta.org/papers/article/32246149
2020-04-23	'Estimating the presymptomatic transmission of COVID19 using incubation period and serial interval data'	'We estimated the fraction and timing of presymptomatic transmissions of COVID19 with mathematical models combining the available data of the incubation period and serial interval. We found that up to 79.7% transmissions could be presymptomatic among the imported cases in China outside Wuhan. The average timing of presymptomatic transmissions is 3.8 days (SD = 6.1) before the symptom onset, which is much earlier than previously assumed.'	2020-04-06	10.1101/2020.04.02.20051318	https://www.meta.org/papers/article/1010051318
2020-04-23	'Widespread use of face masks in public may slow the spread of SARS CoV-2: an ecological study'	'Background The reasons for the large differences between countries in the sizes of their SARS CoV2 epidemics is unknown. Individual level studies have found that the use of face masks was protective for the acquisition and transmission of a range of respiratory viruses including SARS CoV1. We hypothesized that population level usage of face masks may be negatively associated SARS CoV2 spread. Methods At a country level, linear regression was used to assess the association between COVID19 diagnoses per inhabitant and the national promotion of face masks in public (coded as a binary variable), controlling for the age of the COVID19 epidemic and testing intensity. Results Eight of the 49 countries with available data advocated wearing face masks in public: China, Czechia, Hong Kong, Japan, Singapore, South Korea, Thailand and Malaysia. In multivariate analysis face mask use was negatively associated with number of COVID19 cases/inhabitant (coef. -326, 95% CI -601- -51, P=0.021). Testing intensity was positively associated with COVID-19 cases (coef. 0.07, 95% CI 0.05-0.08, P<0.001). Conclusion Whilst these results are susceptible to residual confounding, they do provide ecological level support to the individual level studies that found face mask usage to reduce the transmission and acquisition of respiratory viral infections.'	2020-04-06	10.1101/2020.03.31.20048652	https://www.meta.org/papers/article/1010048652
2020-04-23	'COVID19-Tracker: A shiny app to produce comprehensive data visualization for SARS-CoV-2 epidemic in Spain'	'Data visualization is an essential tool for exploring and communicating findings in medical research, and especially in epidemiological surveillance. The COVID19-Tracker web application systematically produces daily updated data visualization and analysis of the SARS-CoV-2 epidemic in Spain. It collects automatically daily data on COVID-19 diagnosed cases, intensive care unit admissions, and mortality, from February 24th, 2020 onwards. Two applications have already been developed; 1) to analyze data trends and estimating short-term projections; 2) to estimate the case fatality rate, and; 3) To assess the effect of the lockdown measures on the trends of incident data. The application may help for a better understanding of the SARS-CoV-2 epidemic data in Spain.'	2020-04-15	10.1101/2020.04.01.20049684	https://www.meta.org/papers/article/1010049684
2020-04-23	'Exponential phase of covid19 expansion is not driven by climate at global scale'	'The pandemic state of COVID-19 caused by the SARS CoV-2 put the world in quarantine and is causing an unprecedented economic crisis. However, COVID-19 is spreading in different rates at different countries. Here, we tested the effect of three classes of predictors, i.e., socioeconomic, climatic and transport, on the rate of daily increase of COVID-19. We found that global connections, represented by countries importance in the global air transportation network, is the main explanation for the growth rate of COVID-19 in different countries. Climate, geographic distance and socioeconomics did not affect this big picture analysis. Geographic distance and climate were significant barriers in the past but were surpassed by the human engine that allowed us to colonize almost every corner on Earth. Based on our global analysis, the global network of air transportation could lead to a worst-case scenario of synchronous global pandemic if board control measures in international airports were not taken and are not sustained during this pandemic. Despite all limitations of a global analysis, our results indicate that the current claims that the growth rate of COVID-19 may be lower in tropical countries should be taken very carefully, at risk to disturb well-established and effective policy of social isolation that may help to avoid higher mortality rates due to collapse of national health systems. This is the case of Brazil, a well-connected tropical country that presents the second highest increase rate of COVID-19 and might experience a serious case of human-induced disasters if decision makers take into consideration unsupported claims of the growth rate of COVID-19 might be lower in tropical countries.'	2020-04-06	10.1101/2020.04.02.20050773	https://www.meta.org/papers/article/1010050773
2020-04-23	'A mechanistic population balance model to evaluate the impact of interventions on infectious disease outbreaks: Case for COVID19'	'Infectious diseases, especially when new and highly contagious, could be devastating producing epidemic outbreaks and pandemics. Predicting the outcomes of such events in relation to possible interventions is crucial for societal and healthcare planning and forecasting of resource needs. Deterministic and mechanistic models can capture the main known phenomena of epidemics while also allowing for a meaningful interpretation of results. In this work a deterministic mechanistic population balance model was developed. The model describes individuals in a population by infection stage and age group. The population is treated as in a close well mixed community with no migrations. Infection rates and clinical and epidemiological information govern the transitions between stages of the disease. The present model provides a steppingstone to build upon and its current low complexity retains accessibility to non experts and policy makers to comprehend the variables and phenomena at play. The impact of specific interventions on the outbreak time course, number of cases and outcome of fatalities were evaluated including that of available critical care. Data available from the COVID19 outbreak as of early April 2020 was used. Key findings in our results indicate that (i) universal social isolation measures appear effective in reducing total fatalities only if they are strict and the number of daily social interactions is reduced to very low numbers; (ii) selective isolation of only the elderly (at higher fatality risk) appears almost as effective in reducing total fatalities but at a much lower economic damage; (iii) an increase in the number of critical care beds could save up to eight lives per extra bed in a million population with the current parameters used; (iv) the use of protective equipment (PPE) appears effective to dramatically reduce total fatalities when implemented extensively and in a high degree; (v) infection recognition through random testing of the population, accompanied by subsequent (self) isolation of infected aware individuals, can dramatically reduce the total fatalities but only if conducted extensively to almost the entire population and sustained over time; (vi) ending isolation measures while R0 values remain above 1.0 (with a safety factor) renders the isolation measures useless and total fatality numbers return to values as if nothing was ever done; (vii) ending the isolation measures for only the population under 60 y/o at R0 values still above 1.0 increases total fatalities but only around half as much as if isolation ends for everyone; (viii) a threshold value, equivalent to that for R0, appears to exist for the daily fatality rate at which to end isolation measures, this is significant as the fatality rate is (unlike R0) very accurately known. Any interpretation of these results for the COVID19 outbreak predictions and interventions should be considered only qualitatively at this stage due to the low confidence (lack of complete and valid data) on the parameter values available at the time of writing. Any quantitative interpretation of the results must be accompanied with a critical discussion in terms of the model limitations and its frame of application.'	2020-04-07	10.1101/2020.04.04.20053017	https://www.meta.org/papers/article/1010053017
2020-04-23	'N95 Mask Decontamination using Standard Hospital Sterilization Technologies'	'The response to the COVID19 epidemic is generating severe shortages of personal protective equipment around the world. In particular, the supply of N95 respirator masks has become severely depleted with supplies having to be rationed and health care workers having to use masks for prolonged periods in many countries. We sought to test the ability of 4 different decontamination methods including autoclave treatment, ethylene oxide gassing, ionized hydrogen peroxide fogging and vaporized hydrogen peroxide exposure to decontaminate 4 different N95 masks of experimental contamination with SARS-CoV-2 or vesicular stomatitis virus as a surrogate. In addition, we sought to determine whether masks would tolerate repeated cycles of decontamination while maintaining structural and functional integrity. We found that one cycle of treatment with all modalities was effective in decontamination and was associated with no structural or functional deterioration. Vaporized hydrogen peroxide treatment was tolerated to at least 5 cycles by masks. Most notably, standard autoclave treatment was associated with no loss of structural or functional integrity to a minimum of 10 cycles for the 3 pleated mask models. The molded N95 mask however tolerated only 1 cycle. This last finding may be of particular use to institutions globally due to the virtually universal accessibility of autoclaves in health care settings.'	2020-04-20	10.1101/2020.04.05.20049346	https://www.meta.org/papers/article/1010049346
2020-04-23	'An evidence-based framework for priority clinical research questions for COVID-19'	'On 31 December, 2019, the World Health Organization China Country Office was informed of cases of pneumonia of unknown aetiology. Since then, there have been over 75\u2009000 cases globally of the 2019 novel coronavirus (COVID-19), 2000 deaths, and over 14\u2009000 cases recovered. Outbreaks of novel agents represent opportunities for clinical research to inform real-time public health action. In 2018, we conducted a systematic review to identify priority research questions for Severe Acute Respiratory Syndrome-related coronavirus (SARS-CoV) and Middle East Respiratory Syndrome-related coronavirus (MERS-CoV). Here, we review information available on COVID-19 and provide an evidenced-based framework for priority clinical research in the current outbreak. Three bibliographic databases were searched to identify clinical studies published on SARS-CoV and MERS-CoV in the outbreak setting. Studies were grouped thematically according to clinical research questions addressed. In February 2020, available information on COVID19 was reviewed and compared to the results of the SARS-CoV and MERS-CoV systematic review. From the research objectives for SARS-CoV and MERS-CoV, ten themes in the literature were identified: Clinical characterisation, prognosis, diagnosis, clinical management, viral pathogenesis, epidemiological characterisation, infection prevention and control/transmission, susceptibility, psychosocial, and aetiology. For COVID19, some information on clinical presentation, diagnostic testing, and aetiology is available but many clinical research gaps have yet to be filled. Based on a systematic review of other severe coronaviruses, we summarise the state of clinical research for COVID-19, highlight the research gaps, and provide recommendations for the implementation of standardised protocols. Data based on internationally standardised protocols will inform clinical practice real-time.'	2020-04-08	10.7189/jogh.10-011001	https://www.meta.org/papers/article/32257173
2020-04-23	'CoViD19 Meta heuristic optimization based forecast method on time dependent bootstrapped data'	'A compounded method, exploiting the searching capabilities of an operation research algorithm and the power of bootstrap techniques, is presented. The resulting algorithm has been successfully tested to predict the turning point reached by the epidemic curve followed by the CoViD19 virus in Italy. Futures lines of research, which include the generalization of the method to a broad set of distribution, will be finally given.'	2020-04-09	10.1101/2020.04.02.20050153	https://www.meta.org/papers/article/1010050153
2020-04-23	'IV anakinra for macrophage activation syndrome may hold lessons for treatment of cytokine storm in the setting of COVID19'	'Macrophage activation syndrome (MAS) and hemophagocytic lymphohistiocytosis (HLH) are increasingly recognized as being on a continuum, with different initiating pathways culminating in cytotoxic dysfunction and uncontrolled activation and proliferation of T lymphocytes and macrophages. The activated immune cells produce large amounts of proinflammatory cytokines, including IL-1 and IL-6, creating a "cytokine storm" (1, 2). HLH can be familial (primary) or acquired (secondary to conditions such as infection, malignancy, or active autoimmune or autoinflammatory disease). Secondary HLH (sHLH) in association with autoimmune or autoinflammatory disease is referred to as macrophage activation syndrome (MAS). Forms of sHLH have a lower mortality rate than primary HLH (pHLH).'	2020-04-09	10.1002/acr2.11140	https://www.meta.org/papers/article/32267072
2020-04-23	'Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension'	'Cardiovascular diseases, in particular hypertension, as well as the cardiovascular treatment with Renin-Angiotensin System inhibitors such as Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARBs), are claimed once again as mechanisms of Severe Acute Respiratory Syndrome (SARS) during the COVID-19 outbreak due to Cov-2 epidemics. In vitro studies are available to support the eventual role of ACE inhibitors and ARBs in both the promotion and antagonism of the disease. The available literature, indeed, presents contrasting results, all concentrated in experimental models. Evidence in humans is lacking that those mechanisms are\xa0actually occurring in the present COVID-19 outbreak. Here we present the reasoned statement of the Italian Society of Hypertension to maintain ongoing antihypertensive treatments. Furthermore, the Italian Society of Hypertension presents its own initiative to investigate the issue using an online questionnaire to collect relevant data in human disease.'	2020-04-09	10.1007/s40292-020-00380-3	https://www.meta.org/papers/article/32266708
2020-04-23	'A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)'	'Coronavirus disease 2019 (COVID-19) is a declared global pandemic. There are multiple parameters of the clinical course and management of the COVID-19 that need optimization. A hindrance to this development is the vast amount of misinformation present due to scarcely sourced manuscript preprints and social media. This literature review aims to presents accredited and the most current studies pertaining to the basic sciences of SARS-CoV-2, clinical presentation and disease course of COVID-19, public health interventions, and current epidemiological developments. The review on basic sciences aims to clarify the jargon in virology, describe the virion structure of SARS-CoV-2 and present pertinent details relevant to clinical practice. Another component discussed is the brief history on the series of experiments used to explore the origins and evolution of the phylogeny of the viral genome of SARS-CoV-2. Additionally, the clinical and epidemiological differences between COVID-19 and other infections causing outbreaks (SARS, MERS, H1N1) are elucidated. Emphasis is placed on evidence-based medicine to evaluate the frequency of presentation of various symptoms to create a stratification system of the most important epidemiological risk factors for COVID-19. These can be used to triage and expedite risk\xa0assessment.\xa0Furthermore, the limitations and statistical strength of the diagnostic tools currently in clinical practice are evaluated. Criteria on rapid screening, discharge from hospital and discontinuation of self-quarantine are clarified. Epidemiological factors influencing the rapid rate of spread of the SARS-CoV-2 virus are described. Accurate information pertinent to improving prevention strategies is also discussed. The penultimate portion of the review aims to explain the involvement of micronutrients such as vitamin C and vitamin D\xa0in COVID19 treatment and prophylaxis. Furthermore, the biochemistry of the major candidates for novel therapies is briefly reviewed and a summary of their current status in the clinical trials is presented. Lastly, the current scientific data and status of governing bodies such as the Center of Disease Control (CDC) and the WHO on the usage of controversial therapies such as angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs) (Ibuprofen), and corticosteroids usage in COVID-19 are discussed. The composite collection of accredited studies on each of these subtopics of COVID-19 within this review will enable clarification and focus on the current status and direction\xa0in the planning of the management of this global pandemic.'	2020-04-10	10.7759/cureus.7560	https://www.meta.org/papers/article/32269893
2020-04-23	'Data model to predict prevalence of COVID-19 in Pakistan'	'Coronavirus disease 2019 (COVID19) has spread to 181 countries and regions and leaving behind 1,133,788 confirmed cases and 62784 deaths worldwide. Countries with lower health services and facilities like Pakistan are on great risk. Pakistan so far has 3,277 confirmed cases and 50 reported deaths due to COVID19. Various mathematical models had presented to predict the global and regional size of pandemic. However, all those models have certain limitation due to their dependence on different variables and analyses are subject to potential bias. As each country has its own dimension therefore country specific model are required to develop accurate estimate. Here we present a data model to predict the size of COVID19 in Pakistan. In this mathematical data model, we used the time sequence mean weighting (TSMW) to estimate the expected future number of COVID19 cases in Pakistan until 29th April 2020. For future expected numbers of cases for long terms the data collection have to be maintained in real time.'	2020-04-10	10.1101/2020.04.06.20055244	https://www.meta.org/papers/article/1010055244
2020-04-23	'COVID19 Prevention & Care; A Cancer Specific Guideline'	'On March 11th 2020, the coronavirus outbreak was declared a pandemic by the WHO. One of the groups that is considered high risk in this pandemic are cancer patients as they are treated with a variety of immune system suppressor treatment modalities and this puts them in a great risk for infectious disease (including COVID-19). Therefore, cancer patients require higher level measures for preventing and treating infectious diseases. furthermore, cancer patients may bear additional risk due to the restriction of access to the routine diagnostic and therapeutic services during such epidemic. Since most of the attention of health systems is towards patients affected with COVID-19, the need for structured and unified approaches to COVID-19 prevention and care specific to cancer patients and cancer centers is felt more than ever. This article provides the recommendations and possible actions that should be considered by patients, their caregivers and families, physician, nurses, managers and staff of medical centers involved in cancer diagnosis and treatment. We pursued two major goals in our recommendations: first, limiting the exposure of cancer patients to medical environments and second, modifying the treatment modalities in a manner that reduces the probability of myelosuppression such as delaying elective diagnostic and therapeutic services, shortening the treatment course, or prolonging the interval between treatment courses.'	2020-04-10	10.34172/aim.2020.07	https://www.meta.org/papers/article/32271599
2020-04-23	'Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID19 Pandemic'	"In a matter of weeks, the COVID19 crisis has totally upended clinical medicine and the practice of rheumatology. Our old ways of seeing patients in person, precepting fellows in clinic or on the consult service, and leading in-person interactive teaching rounds are gone for now and possibly for good. But how can we replace these critical teaching and training elements? Despite the mounting challenges of managing an exploding population of coronavirus infected patients and caregivers, we must find innovative ways to foster our trainees' professional development."	2020-04-10	10.1002/art.41278	https://www.meta.org/papers/article/32270923
2020-04-23	'Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand"'	'A recent manuscript (Ferguson et al. in Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand, Imperial College COVID-19 Response Team, London, 2020. https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf) from Imperial College modelers examining ways to mitigate and control the spread of COVID-19 has attracted much attention. In this paper, we will discuss a coarse taxonomy of models and explore the context and significance of the Imperial College and other models in contributing to the analysis of COVID-19.'	2020-04-10	10.1007/s11538-020-00726-x	https://www.meta.org/papers/article/32270376
2020-04-23	'The Exponentially Increasing Rate of Patients Infected with COVID-19 in Iran'	'Coronavirus, the cause of severe acute respiratory syndrome (COVID-19), is rapidly spreading around the world. Since the number of corona positive patients is increasing sharply in Iran, this study aimed to forecast the number of newly infected patients in the coming days in Iran. The data used in this study were obtained from daily reports of the Iranian Ministry of Health and the datasets provided by the Johns Hopkins University including the number of new infected cases from February 19, 2020 to March 21, 2020. The autoregressive integrated moving average (ARIMA) model was applied to predict the number of patients during the next thirty days. The ARIMA model forecasted an exponential increase in the number of newly detected patients. The result of this study also show that if the spreading pattern continues the same as before, the number of daily new cases would be 3574 by April 20. Since this disease is highly contagious, health politicians need to make decisions to prevent its spread; otherwise, even the most advanced and capable health care systems would face problems for treating all infected patients and a substantial number of deaths will become inevitable.'	2020-04-10	10.34172/aim.2020.03	https://www.meta.org/papers/article/32271595
2020-04-23	'Why does Japan have so few cases of COVID19?'	'There is a lot of interest brewing as to why Japan has such low numbers of confirmed infected cases of the COVID19 disease, caused by the SARS-COV-2 virus (Figure. 1), despite its high population density (over 6,100 persons/sqkm in Tokyo, 2.4 times higher than New York City) and large percentage of high-risk individuals over 65 years of age (about 26%, compared with 15% in the USA). In Singapore and Hong Kong, rapid and strict quarantine rules and contact tracing has helped to "flatten the curve".'	2020-04-11	10.15252/emmm.202012481	https://www.meta.org/papers/article/32275804
2020-04-23	'Prediction on Covid-19 epidemic for different countries: Focusing on South Asia under various precautionary measures'	'The coronavirus disease 2019 (COVID-19), which emerged from Wuhan, China, is now a pandemic, affecting across the globe. Government of different countries have developed and adopted various policies to contain this epidemic and the most common were the social distancing and lockdown. We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April, 2020, freely available in GitHub repository for COVID-19, for nine developed and developing countries. We used the estimated parameters to predict the disease burden in these countries with special emphasis on India, Bangladesh and Pakistan. Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society. With the current human-to-human transmission rate and existing level of personal precautionary, the number of infected individuals in India will be increasing at least for the next 3 months and the peak will come in 5 months. We can, however, reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities. We need to wait for another one month to obtain more data and epidemiological parameters for giving a better prediction about the pandemic. It is to be mentioned that research community is working for drugs and/ or vaccines against COVID19 and the presence of such pharmaceutical interventions will significantly alter the results.'	2020-04-11	10.1101/2020.04.08.20055095	https://www.meta.org/papers/article/1010055095
2020-04-23	'Infoveillance based on Social Sensors to Analyze the impact of Covid19 in South American Population'	'Infoveillance is an application from Infodemiology field with the aim to monitor public health and create public policies. Social sensor is the people providing thought, ideas through electronic communication channels(i.e. Internet). The actual scenario is related to tackle the covid19 impact over the world, many countries have the infrastructure, scientists to help the growth and countries took actions to decrease the impact. South American countries have a different context about Economy, Health and Research, so Infoveillance can be a useful tool to monitor and improve the decisions and be more strategical. The motivation of this work is analyze the capital of Spanish Speakers Countries in South America using a Text Mining Approach with Twitter as data source. The preliminary results helps to understand what happens two weeks ago and opens the analysis from different perspectives i.e. Economics, Social.'	2020-04-11	10.1101/2020.04.06.20055749	https://www.meta.org/papers/article/1010055749
2020-04-23	'Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology'	'The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions, this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here, we provide a framework for institutions and governments to help adjudicate treatment allocations to patients with neuro-oncologic disease.'	2020-04-11	10.1007/s11060-020-03488-7	https://www.meta.org/papers/article/32274630
2020-04-23	'Introductions and early spread of SARS-CoV-2 in the New York City area'	'New York City (NYC) has emerged as one of the epicenters of the current SARS-CoV2 pandemic. To identify the early events underlying the rapid spread of the virus in the NYC metropolitan area, we sequenced the virus causing COVID19 in patients seeking care at the Mount Sinai Health System. Phylogenetic analysis of 84 distinct SARS-CoV2 genomes indicates multiple, independent but isolated introductions mainly from Europe and other parts of the United States. Moreover, we find evidence for community transmission of SARS-CoV2 as suggested by clusters of related viruses found in patients living in different neighborhoods of the city.'	2020-04-16	10.1101/2020.04.08.20056929	https://www.meta.org/papers/article/1010056929
2020-04-23	'Fear of exponential growth in Covid19 data of India andfuture sketching'	'We have attempted to interpret existing n-cov positive data in India with respect to other countries - Italy, USA, China and South Korea. We have mainly zoomed in the exponential growth in a particular zone of time axis, which is well followed in the data profile of India and Italy but not in others. A deviation from exponential growth to Sigmoid function is analyzed in the data profile of China and South Korea. Projecting that pattern to time dependent data of total number and new cases in India, we have drawn three possible Sigmoid functions, which saturate to cases 10 4 , 10 5 , 10 6 . Ongoing data has doubtful signal of those possibilities and future hope is probably in extension of lock-down and additional imposition of interventions.'	2020-04-11	10.1101/2020.04.09.20058933	https://www.meta.org/papers/article/1010058933
2020-04-23	'Association Between BCG Policy is Significantly Confounded by Age and is Unlikely to Alter Infection or Mortality Rates'	'Recently a number of publications looked at the association between COVID-19 morbidity and mortality on one hand and countries\' policies with respect to BCG vaccination on the other. This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place. In at least 2 preprint publications the authors expressed the view that the "known immunological benefits" of BCG vaccination may be behind the biological mechanism of such observation. One study accounted for different income levels in different groups. Another study did not attempted to do so, instead exploring the differences between countries where a booster shot is given vs others where no such practice exists (finding no connection). Both of these studies did not explore other potential confounding factors. Meanwhile the press has focused on these headlines and pushed the narrative that BCG vaccination is causally linked to infection and mortality rates. This poses a serious challenge, demonstrated by the recently initiated clinical trials on BCG vaccination within the COVID19 context. This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation. It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors, such as population age, ethnicity, rates of certain chronic diseases, time from community spread start date, major public policy decisions and income levels.'	2020-04-11	10.1101/2020.04.06.20055616	https://www.meta.org/papers/article/1010055616
2020-04-23	'Simplified model of the number of Covid-19 patients in the ICU: update April 6, 2020'	'INTRODUCTION: Predicting the number of Covid19 patients in the Intensive Care Units (ICU) could be useful to avoid the breaking point. We attempted to deduce a formula in order to model the number of the ICU patients in France from the official data and patient turnover in the ICU. METHODS: The Covid19 ICU patient turnover was calculated using a recurrence relation from the internal data provided by Hospices Civils de Lyon. The number of new Covid19 cases detected daily was modelized to fit with the last known data in France and extrapolated for the coming days using two scenarios following the existing data in China (best scenario) and Italy (worst scenario). The number of daily admissions in ICU was calculated as the sum of 13.7% of the new Covid19 cases detected on a given day and 7.8% of the average of the total new Covid-19 cases recorded in the last week. Approximately 39.7% of patients admitted to the ICU were non-intubated with an average ICU length of stay of 4 days. Conversely, 60.3% of patients were intubated and for those who died among them (14.44%) the ICU length of stay was of 4 days for 78.3% of them and of 15 days for 21.7% of them. For the intubated patients that were discharged alive, the ICU length of stay was of 6 days for 44.4% of them and of 20 days for 55.6% of them. RESULTS: We predict a peak of between 7072 and 8043 patients for the overall French territory. CONCUSION: Despite a simplified mathematical model, the strength of our study is a narrow possible range of predicted total number of ICU patients.'	2020-04-11	10.1101/2020.04.07.20056226	https://www.meta.org/papers/article/1010056226
2020-04-23	'SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria'	'Community transmission of SARS-CoV-2 was detected in Spain in February 2020, with 216% intensive care unit (ICU) capacity expanded in Vitoria by March 18th, 2020. We identified patients from the two public hospitals in Vitoria who were admitted to ICU with confirmed infection by SARS-CoV-2. Data reported here were available in March 31th, 2020. Mortality was assessed in those who completed 7-days of ICU stay. We identified 48 patients (27 males) with confirmed SARS-CoV-2. Median [interquartile range (IQR)] age of patients was 63 [51-75] years. Symptoms began a median of 7 [5-12] days before ICU admission. The most common comorbidities identified were obesity (n = 48%), arterial hypertension (n = 44%) and chronic lung disease (n = 37%). All patients were admitted by hypoxemic respiratory failure and none received non-invasive mechanical ventilation. Forty-five (94%) underwent intubation, 3 HFNT, 1 (2%) extracorporeal membrane oxygenation (ECMO) and 22 (49%) required prone position. After 15 days, 14/45 (31%) intubated patients died (13% within one week), 10 (22%) were extubated, and 21/45 (47%) underwent mechanical ventilation. Six patients had documented co-infection. Procalcitonin plasma above 0.5 g/L was associated with 16% vs. 19% (p = 0.78) risk of death after 7 days. This early experience with SARS-CoV-2 in Spain suggests that a strategy of right oxygenation avoiding non-invasive mechanical ventilation was life-saving. Seven-day mortality in SARS-CoV-2 requiring intubation was lower than 15%, with 80% of patients still requiring mechanical ventilation. After 15 days of ICU admission, half of patients remained intubated, whereas one third died.'	2020-04-13	10.1016/j.accpm.2020.04.001	https://www.meta.org/papers/article/32278670
2020-04-23	'Forecasting Covid-19 Outbreak Progression in Italian Regions: A model based on neural network training from Chinese data'	'Background. Epidemiological figures of Covid19 epidemic in Italy are worse than those observed in China. Methods. We modeled the Covid19 outbreak in Italian Regions vs. Lombardy to assess the epidemics progression and predict peaks of new daily infections and total cases by learning from the entire Chinese epidemiological dynamics. We trained an artificial neural network model, a modified auto-encoder with Covid19 Chinese data, to forecast epidemic curve of the different Italian regions, and use the susceptible/exposed/infected/removed (SEIR) compartment model to predict the spreading and peaks. We have estimated the basic reproduction number (R0), which represents the average number of people that can be infected by a person who has already acquired the infection - both by fitting the exponential growth rate of the infection across a one month period, and also by using a day by day assessment, based on single observations. Results. The expected peak of SEIR model for new daily cases was at the end of March at national level. The peak of overall positive cases is expected by April 11th in Southern Italian Regions, a couple of days after that of Lombardy and Northern regions. According to our model, total confirmed cases in all Italy regions could reach 160,000 cases by April 30th and stabilize at a plateau. Conclusions. Training neural networks on Chinese data and use the knowledge to forecast Italian spreading of Covid19 has resulted in a good fit, measured with the mean average precision between official Italian data and the forecast.'	2020-04-14	10.1101/2020.04.09.20059055	https://www.meta.org/papers/article/1010059055
2020-04-23	'The VACCINES Act, Deciphering Vaccine Hesitancy in the Time of COVID19'	'None'	2020-04-14	10.1093/cid/ciaa433	https://www.meta.org/papers/article/32282038
2020-04-23	'Navigating Nonessential Research Trials During COVID19: The Push We Needed For Using Digital Technology To Increase Access For Rural Participants?'	'None'	2020-04-14	10.1111/jrh.12446	https://www.meta.org/papers/article/32282959
2020-04-23	'Should contact bans be lifted in Germany? A quantitative prediction of its effects'	'Many countries consider the lifting of restrictions of social contacts (RSC). We quantify the effects of RSC for Germany. We initially employ a purely statistical approach to predicting prevalence of COVID19 if RSC were upheld after April 20. We employ these findings and feed them into our theoretical model. We find that the peak of the number of sick individuals would be reached already by mid-April. The number of sick individuals would fall below 1,000 at the beginning of July. When restrictions are lifted completely on April 20, the number of sick should rise quickly again from around April 27. A balance between economic and individual costs of RSC and public health objectives consists in lifting RSC for activities that have high economic benefits but low health costs. In the absence of large-scale representative testing of CoV-2 infections, these activities can most easily be identified if federal states of Germany adopted exit strategies that differ across states.'	2020-04-14	10.1101/2020.04.10.20060301	https://www.meta.org/papers/article/1010060301
2020-04-23	'Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians'	"In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. PubMed and Google Scholar search engines were searched using the key terms 'telemedicine', 'diabetes', 'COVID-19 up to 31st March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed. We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required."	2020-04-14	10.1016/j.dsx.2020.04.001	https://www.meta.org/papers/article/32283497
2020-04-23	'Anosmia and dysgeusia in patients with mild SARS-CoV-2 infection'	'In this cohort of 42 patients with mild COVID19 we describe the unique clinical feature of acute anosmia and dysgeusia in more than third of patients. Median onset of these features was 3.3 days after onset of illness (range 0-7) with rapid recovery in most patient.'	2020-04-14	10.1101/2020.04.11.20055483	https://www.meta.org/papers/article/1010055483
2020-04-23	'Endoscopy units and the COVID-19 Outbreak: A Multi-Center Experience from Italy'	'None'	2020-04-14	10.1053/j.gastro.2020.04.003	https://www.meta.org/papers/article/32283102
2020-04-23	'Possibilities of exponential or Sigmoid growth of Covid19 data in different states of India'	'We have attempted to understand existing covid19 data of India, where growth of total and new cases with time in different states are kept as focal points. Identifying the last trend of exponential growth, mainly noticed in month of March, we have zoomed in its disaster possibilities by straight forward extrapolation of exponential growth. As a hopeful extrapolation, the existing data might be considered low time-axis values of Sigmoid-type function, whose growth might be saturated to values of 10^4 or 10^5. To fulfill this expectation, a turning from increasing to decreasing trend in new case data should be noticed around April-May, which definitely demand extension of present lock-down with additional interventions.'	2020-04-14	10.1101/2020.04.10.20060442	https://www.meta.org/papers/article/1010060442
2020-04-23	'Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know'	'The novel coronavirus (Covid-19) is a family of large enveloped non-segmented positive-sense RNA viruses which has been considered as a global health concern as it has a very high transmissibility potential. Regarding to the similarity of the virus to SARS-CoV, it is postulated that the Covid-19 accumulates mainly in the nasal epithelia and lower respiratory airways. However, there is evidence suggesting the Covid-19 neurotropism which might contribute to respiratory failure. Here in we aim to review the central nervous system complications of the Covid-19 CoV since the emergence of the virus. Keywords: Novel Coronavirus, Covid19-Cov, CNS Complication, Nervous System.'	2020-04-15		https://www.meta.org/papers/article/32285431
2020-04-23	'A survey-based study on the knowledge, attitude, and the practices pertaining to the 2019 novel Corona Virusinfection amongst undergraduate medical students in India'	'Background. In the light of recent outbreak of COVID19 Pandemic for which is there no specific treatment, prevention and awareness is the only key to overcome an adversity of such magnitude. Thus, we aimed to understand the knowledge, attitude and practices of undergraduate medical students pertaining to infection with the COVID19. Methods. An electronic survey developed using an online cloud-based website (Survey Monkey) was served to undergraduate medical students. Participants had a week to voluntarily complete the 8 minute long questionnaire. Descriptive statistics and figures were obtained from surveymonkey.com. Results. Of 2507 invitees across six medical colleges in India, 616 (24.6%) responded. Most undergraduates (age 21.5 years, 46.1% males) were undergoing internship (16.7%) or final year undergraduate training (54.1%). Knowledge regarding viral transmission, clinical-radiologic features, laboratory diagnosis and treatment was adequate among most students (Fig 1). However, the understanding of the incubation period and time to symptoms was less than satisfactory (Supplementary Table 1). Nearly three-fourths 461 (74.8%) were aware of the COVID-19 specific precautions. While their universities had advised most regarding hand hygiene, social distancing, symptom identification, and high-risk groups, fewer were advised to avoid staying back in hostels or drug prevention. Nearly 70% were reluctant to attend clinics from fear of getting infected or passing on to others. Most students read about COVID-19 regularly, and social media accounts of medical journals were the primary 78.9% source. Conclusion. Most medical students are aware of the basics of COVID19 infection and act as a potential reservoir to fill the gaps in Healthcare services should the need arise.'	2020-04-15	10.1101/2020.04.11.20061333	https://www.meta.org/papers/article/1010061333
2020-04-23	'COVID-19: A model correlating BCG vaccination to protection from mortality implicates trained immunity'	'We use a data quality model to demonstrate that BCG vaccination is correlated with protection from death from COVID19. From a mechanistic perspective, BCG is well described to elicit its protective non-specific effects through the process of trained immunity. Therapeutically enhancing trained immunity may therefore be an important mechanism in protection from the lethal effects of COVID19'	2020-04-15	10.1101/2020.04.10.20060905	https://www.meta.org/papers/article/1010060905
2020-04-23	'Issues relevant to mental health promotion in frontline health care providers managing quarantined/isolated COVID19 patients'	'None'	2020-04-15	10.1016/j.ajp.2020.102084	https://www.meta.org/papers/article/32289728
2020-04-23	'Navigating the Ethics of COVID-19 in Otolaryngology'	'The COVID-19 pandemic has dramatically altered how otolaryngologists contemplate and assume their roles in health care delivery. The ethical implications of this pandemic upon our practice are formidable and distinct from other surgical fields. The salient ethical issues of public health stewardship and safety, distributive justice, and nonabandonment are distilled for the practicing otolaryngologist.'	2020-04-15	10.1177/0194599820920850	https://www.meta.org/papers/article/32284004
2020-04-23	'Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19)'	'The pandemic COVID19 pneumonia has engulfed the entire world. Hematopoietic system can also be affected by COVID19. Thrombocytopenia at admission was prevalent, while late phase or delayed phase thrombocytopenia is obscure. This retrospective case series analyzed patients with COVID19 at the Union Hospital, Wuhan, China, from January 25th to March 9th, 2020. Analysis began on March 11th, 2020. COVID19 associated delayed phase thrombocytopenia was occurred in 11.8% percent of enrolled patients. The delayed phase thrombocytopenia in COVID19 is prone to develop in elderly patients or patients with low lymphocyte count on admission. The delayed-phase thrombocytopenia is significantly associated with increased length of hospital stay and higher ICU admission rate. Delayed phase nadir platelet counts demonstrated a high and significantly negative linear correlation with B cell percentages and serum IL 6 levels. We also presented bone marrow aspiration pathology of three patients with delayed phase thrombocytopenia, showing impaired maturation of megakaryocytes. We speculated that the delayed phase platelet destruction might be mediated by antibodies, and suggest immunoregulatory treatment in severe patients to improve outcomes. Besides, clinicians need to pay attention to the delayed phase thrombocytopenia especially at 3 to 4 weeks after symptom onset.'	2020-04-15	10.1101/2020.04.11.20059170	https://www.meta.org/papers/article/1010059170
2020-04-23	'The Heart in COVID19: Primary Target or Secondary Bystander?'	'In the throes of the current COVID-19 pandemic, interest has burgeoned in the cardiovascular complications of this virulent viral infection. As troponin, a biomarker of cardiac injury, often rises in hospitalized patients, its interpretation and actionability require careful consideration. Fulminant myocarditis due to direct viral infection can certainly occur, but patients with increased oxygen demands due to tachycardia and fever, and reduced oxygen delivery due to hypotension and hypoxemia can cause myocardial injury indirectly. Cytokines released during the acute infection can elicit activation of cells within pre-existing atherosclerotic lesions, augmenting thrombotic risk and risk of ischemic syndromes. Moreover, microvascular activation by cytokines can cause not only myocardial injury but harm other organ systems commonly involved in COVID-19 infections including the kidneys. Dealing with the immense challenge of COVID-19 disease, confronted with severely ill patients in dire straits with virtually no rigorous evidence base to guide our therapy, we must call upon our clinical skills and judgment. These touchstones can help guide us in selecting patients who might benefit from the advanced imaging and invasive procedures that present enormous logistical challenges in the current context. Lacking a robust evidence base, pathophysiologic reasoning can help guide our choices of therapy for individual clinical scenarios. We must exercise caution and extreme humility, as often plausible interventions fail when tested rigorously. But act today we must, and understanding the multiplicity of mechanisms of myocardial injury in COVID-19 infection will help us meet our mission unsupported by the comfort of strong data.'	2020-04-16	10.1016/j.jacbts.2020.04.001	https://www.meta.org/papers/article/32292847
2020-04-23	'How to reorganize the access of children in a radiotherapy department in the era of COVID19, in order to protect themselves and elderly patients'	'None'	2020-04-16	10.1016/j.adro.2020.04.002	https://www.meta.org/papers/article/32292845
2020-04-23	'RISK ANALYSIS AND PREDICTION FOR COVID19 DEMOGRAPHICS IN LOW RESOURCE SETTINGS USING A PYTHON DESKTOP APP AND EXCEL MODELS.'	'While the novel covid19 disease caused by sar-cov-2 corona virus has proved a serious threat to mankind it being a pandemic, the rate at which technology in low resource income countries like Uganda has been used to predict the spread and impact of the disease in their economies has not been strongly employed. This paper presents a an excel model and desktop application software developed using open source python programming tools for carrying out risk analysis and prediction of demographics for covid19 disease. Prediction results for both models clearly stated using epidemiological curve, these results can vary based on the force of infection which varies based on government measures and actions. With a certain degree of certainty of the potential impact of the disease on low resource countries, it will foster proper planning and strategical methods to properly manage the pandemic'	2020-04-17	10.1101/2020.04.13.20063453	https://www.meta.org/papers/article/1010063453
2020-04-23	'Public policy and economic dynamics of COVID-19 spread: a mathematical modeling study'	'Summary Background: With the COVID-19 pandemic infecting millions of people, largescale quarantine policies have been enacted across the globe. Understanding how to maximize the effectiveness of these policies while mitigating economic damage is essential. We develop a mathematical model with different levels of population health and economic risk to assess the impact of quarantine measures on deaths, hospitalizations, and economic output. Methods: We combine an extended SEIR model that has multiple levels of health risk and economic vulnerability with disease parameters for the COVID19 pandemic to study the effects of quarantine policies. We examine the dynamics of infectious disease transmission and its economic impact for one year. We populate our model with a baseline of 95.6 % of high-risk people and 85.6 % of low-risk people in quarantine. We use our model to simulate leaving the current quarantine restrictions in place indefinitely. We then assess a policy where quarantine restrictions for lower-risk groups are gradually relaxed. Finally, we simulate relaxing quarantine restrictions more quickly. To compare outbreak outcomes under the same quarantine policies using different disease parameters, we also perform a sensitivity analysis on the contagiousness of infected people, the strictness of social isolation measures, and the amount that public policymakers value the economy in setting quarantine restrictions. Findings: We first consider a baseline scenario with constant quarantine level, finding that in a population of 330,000,000 million, there are 32,023 deaths among those under 60 and 174,682 deaths among those over 60, there is a peak of 189,136 hospitalizations, and the economy relative to the beginning of the quarantine state is 1.4 % smaller. In the scenario where higher-risk people are strictly quarantined, and for others the quarantine is slowly relaxed, there are 63,776 deaths among those under 60, 85,880 deaths among those over 60, a peak of 341,321 hospitalizations, and the economy relative to the beginning of the quarantine state is 6% larger. In the scenario where quarantine is more quickly lifted, there are 25,720 deaths among those under 60, 214,718 deaths among those over 60, a peak of 341,321 hospitalizations, and economic output relative to the beginning of the quarantine state is 4.5 % smaller. Interpretation: Strict restrictions on high-risk patients and a gradual lifting of quarantine for low-risk patients results in a limited number of deaths and lesser economic damage. We recommend this kind of strategy, combined with policies lowering the contagiousness of the disease and making quarantine more tolerable and economically viable for individuals.'	2020-04-17	10.1101/2020.04.13.20062802	https://www.meta.org/papers/article/1010062802
2020-04-23	'Nature of transmission of Covid19 in India'	'We examine available data on the number of individuals infected by the Covid-19 virus, across several different states in India, over the period January 30, 2020 to April 10, 2020. It is found that the growth of the number of infected individuals $N(t)$ can be modeled across different states with a simple linear function $N(t)=\\gamma+\\alpha t$ beyond the date when reasonable number of individuals were tested (and when a countrywide lockdown was imposed). The slope $\\alpha$ is different for different states. Following recent work by Notari (arxiv:2003.12417), we then consider the dependency of the $\\alpha$ for different states on the average maximum and minimum temperatures, the average relative humidity and the population density in each state. It turns out that like other countries, the parameter $\\alpha$, which determines the rate of rise of the number of infected individuals, seems to have a weak correlation with the average maximum temperature of the state. In contrast, any significant variation of $\\alpha$ with humidity or minimum temperature seems absent with almost no meaningful correlation. Expectedly, $\\alpha$ increases (slightly) with increase in the population density of the states; however, the degree of correlation here too is negligible. These results seem to barely suggest that a natural cause like a hot summer (larger maximum temperatures) may contribute towards reducing the transmission of the virus, though the role of minimum temperature, humidity and population density remains somewhat obscure from the inferences which may be drawn from presently available data.'	2020-04-17	10.1101/2020.04.14.20065821	https://www.meta.org/papers/article/1010065821
2020-04-23	'Prediction of COVID-19 transmission dynamics using a mathematical model considering behavior changes'	'Since the report of the first confirmed case in Daegu on February 18, 2020, local transmission of COVID-19 in the Republic of Korea has continued. In this study, we aimed to identify the pattern of local transmission of COVID-19 using mathematical modeling and predict the epidemic size and the timing of the end of the spread. We modeled the COVID-19 outbreak in the Republic of Korea by applying a mathematical model of transmission that factors in behavioral changes. We used the Korea Centers for Disease Control and Prevention data of daily confirmed cases in the country to estimate the nationwide and Daegu/Gyeongbuk area-specific transmission rates as well as behavioral change parameters using a least-squares method. The number of transmissions per infected patient was estimated to be about 10 times higher in the Daegu/Gyeongbuk area than the average of nationwide. Using these estimated parameters, our models predicts that about 13,800 cases will occur nationwide and 11,400 cases in the Daegu/Gyeongbuk area until mid-June. We mathematically demonstrate that the relatively high per-capita rate of transmission and the low rate of changes in behavior have caused a large-scale transmission of COVID-19 in the Daegu/Gyeongbuk area in the Republic of Korea. Since the outbreak is expected to continue until May, nonpharmaceutical interventions that can be sustained over the long term are required.'	2020-04-17	10.4178/epih.e2020026	https://www.meta.org/papers/article/32299157
2020-04-23	'Multinational modeling of SARS-CoV-2 spreading dynamics: Insights on the heterogeneity of COVID-19 transmission and its potential healthcare burden'	'Background: Despite efforts aimed at forecasting the course of the pandemic extrapolating from reports of the early onset in Wuhan, China, heterogeneity in the transmission seems to be an important characteristic of SARS-CoV-2 between countries. The study of the progress of the disease with a single set of transmission parameters is complicated by the application of different levels of containment measures at different stages of the pandemic. Methods: We studied the variation in transmission of COVID-19 globally and individually for 18 countries. We developed a piecewise fitting methodology to model the progress of the COVID-19 epidemic for a set of countries with a number of confirmed infections in excess of 1000 cases. Our study uses the susceptible-exposed-infected-removed (SEIR) model to assess the contagious contact rate ({beta}) of SARS-CoV-2 at different stages of the pandemic as a metric of the effectiveness of policies aimed at reducing the spread of COVID-19. We extrapolate the results of our fittings to evaluate the effect of a reduction of {beta} on the level of burden laid on local health care infrastructure considering different levels of intervention and to estimate the maximum number of cases and potential peak date to inform future public health interventions. Results: According to the current trend, we project that the peak in the number of infections worldwide will take place after the third quarter of 2020. For 12 out of the 17 countries analyzed, the projections suggest that the number of severe infections will surpass the healthcare capacity. Additionally, it is observed that 4 out of the 17 analyzed will undergo a significant delay in the peak of the infection for a 90% reduction of the transmission rate, and thus extending the course of the epidemic further than the 365 day simulation window. COVID19 transmission dynamics are highly heterogeneous and influenced by both, the rate of spread and local response of the public health measures and to a lesser extent, to the compliance of the population. Funding: No funding received.'	2020-04-17	10.1101/2020.04.14.20064956	https://www.meta.org/papers/article/1010064956
2020-04-23	'Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis'	'and aims: To prevent the spread of coronavirus disease (COVID19) total lockdown is in place in India from March 24, 2020 for 21 days. In this study, we aim to assess the impact of the duration of the lockdown on glycaemic control and diabetes-related complications. A systematic search was conducted using Cochrane library. A simulation model was created using glycemic data from previous disasters (taken as similar in impact to current lockdown) taking baseline HBA1c and diabetes-related complications data from India-specific database. A multivariate regression analysis was conducted to analyse the relationship between the duration of lockdown and glycaemic targets & diabetes-related complications. The predictive model was extremely robust (R2\xa0=\xa00.99) and predicted outcomes for period of lockdown up to 90 days. The predicted increment in HBA1c from baseline at the end of 30 days and 45 days lockdown was projected as 2.26% & 3.68% respectively. Similarly, the annual predicted percentage increase in complication rates at the end of 30-day lockdown was 2.8% for non-proliferative diabetic retinopathy, 2.9% for proliferative diabetic retinopathy, 1.5% for retinal photocoagulation, 9.3% for microalbuminuria, 14.2% for proteinuria, 2.9% for peripheral neuropathy, 10.5% for lower extremity amputation, 0.9% for myocardial infarction, 0.5% for stroke and 0.5% for infections. The duration of lockdown is directly proportional to the worsening of glycaemic control and diabetes-related complications. Such increase in diabetes-related complications will put additional load on overburdened healthcare system, and also increase COVID19 infections in patients with such uncontrolled glycemia.'	2020-04-17	10.1016/j.dsx.2020.03.014	https://www.meta.org/papers/article/32298984
2020-04-23	'Learning as We Go: An Examination of the Statistical Accuracy of COVID19 Daily Death Count Predictions'	'A recent model developed at the Institute for Health Metrics and Evaluation (IHME) provides forecasts for ventilator use and hospital beds required for the care of COVID19 patients on a state-by-state basis throughout the United States over the period March 2020 through August 2020 (See the related website https://covid19.healthdata.org/projections for interactive data visualizations). In addition, the manuscript and associated website provide projections of deaths per day and total deaths throughout this period for the entire US, as well as for the District of Columbia. This research has received extensive attention in social media, as well as in the mass media. Moreover, this work has influenced policy makers at the highest levels of the United States government, having been mentioned at White House Press conferences, including March 31, 2020. In this paper, we evaluate the predictive validity of model forecasts for COVID19 outcomes as data become sequentially available, using the IHME prediction of daily deaths. We have found that the predictions for daily number of deaths provided by the IHME model have been highly inaccurate. The model has been found to perform poorly even when attempting to predict the number of next day deaths. In particular, the true number of next day deaths has been outside the IHME prediction intervals as much as 70% of the time.'	2020-04-17	10.1101/2020.04.11.20062257	https://www.meta.org/papers/article/1010062257
2020-04-23	'Time course quantitative detection of SARS-CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases'	'Since many SARS-CoV-2 carriers are assumed to exhibit no or few non-specific symptoms, SARS-CoV-2 circulation among human populations may be detected too lately and only when massive human testing is available or when clinal COVID-19 cases are reported. This is obviously a major pitfall for evaluating and possibly controlling the current epidemic. Due to the presence of SARS-CoV-2 in stool samples qualitative detection of SARS-CoV-2 in wastewaters has recently been proposed as a complementary tool to investigate the virus circulation in human populations. If this assumption is correct, SARS-CoV-2 relative amounts in wastewaters should correlate with the number of confirmed COVID-19 cases. To test this hypothesis, we performed a time-course quantitative analysis of SARS-CoV2 by RT-qPCR in 23 raw and 8 treated wastewater samples collected from 3 major wastewater treatment plant (WWTP) of the Parisian area collecting 3 to 4 million inhabitants reject. This study was conducted from 5 March to 7 April 2020. All raw wastewater samples scored positive for SARS-CoV2. Additionally, 6 out of 8 samples from treated wastewater scored positive by RT-qPCR. Treated wastewater effluents showed a 100 times reduction in the viral load compared to the corresponding raw wastewater samples, which agrees with previous work on enteric viruses. We next compared the average level of SARS-CoV2 genomes in wastewater samples over time with the number of confirmed fatal cases of COVID19 in Paris area and in France As expected, we confirmed that the increase of genome units in raw wastewaters accurately followed the increase in the number of fatal cases observed at the regional and national level Therefore, our study demonstrates that the contamination of wastewater and the detection of viral genome occurred before the beginning of the exponential growth of the epidemic. This work demonstrated that a quantitative monitoring of SARS-CoV2 genomes in wastewaters should bring important and additional information for better survey of SARS-CoV2 circulation at the local or regional scale. Additionally, wastewater survey may provide an alternative and possibly early tool to detect pathogens in populations when investigations in humans is difficult for logistic, ethical or economic reasons.'	2020-04-17	10.1101/2020.04.12.20062679	https://www.meta.org/papers/article/1010062679
2020-04-23	'Forecasting Hospital Staff Availability During The COVID-19 Epidemic'	'The COVID-19 pandemic poses two challenges to healthcare providers. Firstly, a high number of patients require hospital admission. Second, a high number of healthcare staff are either falling ill with the infection, or self-isolating. This poses significant problems for the staffing of busy hospital departments. We have created a simple model which allows users to stress test their rota. The model provides plots of staff availability over time using either a constant infection rate, or a changing infection rate fitted to population-based infection curves. It allows users to gauge the extent and timing of dips in staff availability. The basic constant infection rate model is available within an on-line web application (https://covid19.shef.ac.uk). As for any model, our work is imperfect. However, it allows a range of infection rates to be simulated quickly across different work patterns. We hope it will be useful to those planning staff deployment and will stimulate debate on the most effective patterns of work during the COVID-19 epidemic.'	2020-04-17	10.1101/2020.04.15.20066019	https://www.meta.org/papers/article/1010066019
2020-04-23	'Significantly longer Covid-19 incubation times for the elderly, from a case study of 136 patients throughout China'	'Objective: To infer Covid19 incubation time distribution from a large sample. Method: Based on individual case data published online by 21 cities of China, we investigated a total of 136 COVID19 patients who traveled to Hubei from 21 cities of China between January 5 and January 31, 2020, remained there for 48 hours or less, and returned to these cities with onset of symptoms between January 10 and February 6, 2020. Among these patients, 110 were found to be aged 15 to 64, 22 aged 65 to 86, and 4 aged under 15. Findings: The differential incubation time histogram of the two age groups 15 to 64 and 65 to 86 are adequately fitted by the log normal model. For the 15 to 64 age group, the median incubation time of 7.00+1.10 - 0.9 days (uncertainties are 95 % CL) is broadly consistent with previous literature. For the 65-86 age group, the median is 10.9+2.7 - 2.0 days is statistically significantly longer. Moreover, for this group, the 95 % confidence contour indicates the data cannot constrain the upper bound of the log normal parameters , {sigma} by failing to close there; this is because the sample has a maximum incubation time of 17 days, beyond which we ran out of data even though the histogram has not yet peaked. Thus there is the potential of a much longer incubation time for the 65 to 86 age group than 10 to 14 days. Only a much larger sample can settle this.'	2020-04-18	10.1101/2020.04.14.20065896	https://www.meta.org/papers/article/1010065896
2020-04-23	'SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup'	'In late 2019, cases of atypical pneumonia were detected in China. The etiological agent was quickly identified as a betacoronavirus (named SARS-CoV-2), which has since caused a pandemic. Several methods allowing for the specific detection of viral nucleic acids have been established, but these only allow detection of the virus during a short period of time, generally during acute infection. Serological assays are urgently needed to conduct serosurveys, to understand the antibody responses mounted in response to the virus, and to identify individuals who are potentially immune to re-infection. Here we describe a detailed protocol for expression of antigens derived from the spike protein of SARS-CoV-2 that can serve as a substrate for immunological assays, as well as a two-stage serological enzyme-linked immunosorbent assay (ELISA). These assays can be used for research studies and for testing in clinical laboratories.  2020 The Authors. Basic Protocol 1: Mammalian cell transfection and protein purification Basic Protocol 2: A two-stage ELISA for high-throughput screening of human serum samples for antibodies binding to the spike protein of SARS-CoV-2.'	2020-04-18	10.1002/cpmc.100	https://www.meta.org/papers/article/32302069
2020-04-23	'Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland'	"Coronavirus (COVID-19) is highly infectious agent that causes fatal respiratory illnesses, which is of great global public health concern. Currently, there is no effective vaccine for tackling this COVID19 pandemic where disease countermeasures rely upon preventing or slowing person-to-person transmission. Specifically, there is increasing efforts to prevent or reduce transmission to front-line healthcare workers (HCW). However, there is growing international concern regarding the shortage in supply chain of critical one-time-use personal and protective equipment (PPE). PPE are heat sensitive and are not, by their manufacturer's design, intended for reprocessing. Most conventional sterilization technologies used in hospitals, or in terminal medical device sterilization providers, cannot effectively reprocess PPE due to the nature and severity of sterilization modalities. Contingency planning for PPE stock shortage is important. Solutions in the Republic of Ireland include use of smart communication channels to improve supply chain, bespoke production of PPE to meets gaps, along with least preferred option, use of sterilization or high-level disinfection for PPE reprocessing. Reprocessing PPE must consider material composition, functionality post treatment, along with appropriate disinfection. Following original manufacturer of PPE and regulatory guidance is important. Technologies deployed in the US, and for deployment in the Republic of Ireland, are eco-friendly, namely vaporised hydrogen peroxide (VHP), such as for filtering facepiece respirators and UV irradiation and High-level liquid disinfection (Actichlor+) is also been pursed in Ireland. Safeguarding supply chain of PPE will sustain vital healthcare provision and will help reduce mortality."	2020-04-19	10.1016/j.scitotenv.2020.138532	https://www.meta.org/papers/article/32304970
2020-04-23	'Quantitative form and fit of N95 filtering facepiece respirators are retained after dry and humid heat treatments for coronavirus deactivation'	'Re-use of filtering facepiece respirators (FFRs, or commonly referred to as N95s) normally meant for single use only is becoming common in healthcare facilities due to shortages caused by the COVID19 pandemic. Here, we report the results of quantitative fit tests of FFRs after heat treatments at 75 {degrees}C both under dry and humid (90% relative humidity) conditions. These conditions have been previously reported to deactivate coronaviruses (including SARS-CoV-2) while maintaining filter efficiency. FFRs passed quantitative fit tests after undergoing both single and ten heating cycles under both dry and humid conditions. These results suggest that thermal deactivation of coronaviruses is a potentially rapid and widely deployable method to re-use N95 FFRs in emergency situations where re-using masks is a necessity and broad-spectrum sterilization is unavailable.'	2020-04-20	10.1101/2020.04.15.20065755	https://www.meta.org/papers/article/1010065755
2020-04-23	'The impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysis'	'Evidence about COVID-19 on cardiac injury is inconsistent. We aimed to summarize available data on severity differences in acute cardiac injury and acute cardiac injury with mortality during the COVID-19 outbreak. We performed a systematic literature search across Pubmed, Embase and pre-print from December 1, 2019 to March 27, 2020, to identify all observational studies that reported cardiac specific biomarkers (troponin, creatine kinase-MB fraction, myoglobin, or NT-proBNP) during COVID-19 infection. We extracted data on patient demographics, infection severity, comorbidity history, and biomarkers during COVID-19 infection. Where possible, data were pooled for meta-analysis with standard (SMD) or weighted (WMD) mean difference and corresponding 95% confidence intervals (CI). We included 4189 confirmed COVID-19 infected patients from 28 studies. More severe COVID-19 infection is associated with higher mean troponin (SMD 0.53, 95% CI 0.30 to 0.75, p\u202f<\u202f0.001), with a similar trend for creatine kinase-MB, myoglobin, and NT-proBNP. Acute cardiac injury was more frequent in those with severe, compared to milder, disease (risk ratio 5.99, 3.04 to 11.80; p\u202f<\u202f0.001). Meta regression suggested that cardiac injury biomarker differences of severity are related to history of hypertension (p\u202f=\u202f0.030). Also COVID19-related cardiac injury is associated with higher mortality (summary risk ratio 3.85, 2.13 to 6.96; p\u202f<\u202f0.001). hsTnI and NT-proBNP levels increased during the course of hospitalization only in non-survivors. The severity of COVID-19 is associated with acute cardiac injury, and acute cardiac injury is associated with death. Cardiac injury biomarkers mainly increase in non-survivors. This highlights the need to effectively monitor heart health to prevent myocarditis in patients infected with COVID-19.'	2020-04-20	10.1016/j.pcad.2020.04.008	https://www.meta.org/papers/article/32305557
2020-04-23	'COVID19 during pregnancy: a systematic review of reported cases'	'to conduct a systematic review of the outcomes reported for pregnant patients with COVID 19. we searched electronically Pubmed, Cinahl, Scopus using combination of keywords "Coronavirus and/ or pregnancy"; "COVID and/or pregnancy"; "COVID disease and/or pregnancy"; "COVID pneumonia and/or pregnancy. There were no restriction of languages in order to collect as much cases as possible. all pregnant women, with a COVID19 diagnosed with acid nucleic test, with reported data about pregnancy and, in case of delivery, reported outcomes. all the studies included have been evaluated according the tool for evaluating the methodological quality of case reports and case series described by Murad et al. RESULTS: 6 studies including 51 women were eligible for the systematic review. Three pregnancies were ongoing at the time of the report; of the remaining 48, 46 were delivered with a cesarean section and 2 vaginally; there was 1 stillbirth and 1 neonatal death. although vertical transmission of SARS-Cov2 has been excluded thus far and the outcome for mothers and fetuses has been generally good, the high rate of preterm cesarean delivery is a reason for concern. These interventions were typically elective, and it is reasonable to question whether they were warranted or not. COVID-19 associated with respiratory insufficiency in late pregnancies certainly creates a complex clinical scenario.'	2020-04-21	10.1016/j.ajog.2020.04.013	https://www.meta.org/papers/article/32311350
2020-04-23	'Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines'	'Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months, causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation abnormalities, which may occur in almost all of the severe and critical ill COVID-19 cases. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has been frequently reported in COVID-19 cases, but its management is still challenging due to the complexity between antithrombotic therapy and coagulation disorders. Based on frontline practical experience and comprehensive literature review, here a panel of experts and physicians from China and Europe developed an evidence and opinion-based consensus on the prophylaxis and management of VTE associated with COVID-19. This statement aims for clinicians treating COVID-19 and provides practical recommendations in detailed situations, for example, how to choose thromboprophylactic measures for patients with diverse severity of disease and bleeding risk, or which kind of anticoagulant should be prescribed. With limited experience on COVID19-associated VTE, this expert consensus statement should be helpful for clinicians worldwide with specific suggestions.'	2020-04-22	10.1055/s-0040-1710019	https://www.meta.org/papers/article/32316065
